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ABSTRACT

When combining imaging and therapeutic motifs, known as theranostics, amphiphilic diblock copolymers have a strong precedent of success.1 These polymers can
self-assemble into a variety of morphologies that are known to concentrate in areas of
inflammation such as tumors.2 However, prediction of size and morphology from polymer
structure (QSPR) still remains an open challenge.3 Another system with promise of therapeutic eﬀicacy are tree-like structures known as dendrimers, such as poly(amidoamine)
(PAMAM) and bis-(hydroxymethyl) propionic acid (bMPA), which can uptake drugs and
dyes into their branches.4 Combining these two motifs into linear-dendritic block copolymers (LDBCs) represents significant synthetic diﬀiculty. Herein is presented novel synthetic routes and characterization for two systems of LDBCs. The first is a QSPR study ofbiocompatible PAMAM-polylactide (PLA) hybrid, synthesized with different PLA chain
lengths and tacticities. This work developed an eﬀicient synthetic route to these polymers,
which were found to self-assemble into monodisperse spheres. The second system involves
in-situ self-assembly, known as polymerization-induced self-assembly (PISA). LDBCs derived from bMPA dendrons and linear portions, consisting of benzyl and trifluoroethyl
methacrylate, were synthesized for the first time. This allowed more precise examination
of QSPR at industrially relevant concentrations, and revealed a difference in mechanism
for the self-assembly of each polymer. This represents the first time LDBCs have been
studied by PISA, allowing the variety of applications of PISA formulations to have unprecedented access to the unique advantages of dendrimers.
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CHAPTER 1: BACKGROUND: TARGETED DRUG
DELIVERY AND IMAGING

1.1 Targeted Drug Delivery
1.1.1 Absorbance, Distribution, Metabolism, Excretion
One of the major problems in modern medicine is selectivity.6 If taken either
orally or intravenously, the traditional mechanism of drug delivery is the drug spreading
throughout the body using a large enough dosage that a therapeutic amount reaches
the affected area. This is problematic with expensive or potentially toxic drugs. The
drug must be absorbed, distributed, metabolized, and excreted (ADME) in addition to
being pharmocologically active in the first place. Various approaches have been taken
to alleviate issues with ADME, with some of the first including encapsulating the drug
in lipid micelles,7 embedding it in a cross-linked polymer,8 or attaching it to a silicabased nanoparticle. These approaches have led toward the goal of targeted drug delivery
(TDD).9 Although drugs commonly work by binding to the active site of a protein, one
potential mechanism of increasing TDD is simply changing the structure of the drug to
increase binding strength. This is often quite diﬀicult due to both the synthetic diﬀiculty
of drug molecules, and the diﬀiculty of predicting cytotoxicity. The latter problem is
amplified by the potential cytotoxicity of primary and secondary metabolites, even if the
drug itself bears no risk.
A popular heuristic for predicting ADME is Lipinski’s rule of five.10 This was
originally based on the observation that most orally administered drugs are moderately
1

lipophilic. This is reflected in the final rule, which states the drug’s octanol/water partition coeﬀicient (logP) should not be greater than 5. Modern TDD systems therefore
allow for a broader drug design space by effectively acting as solubilizing agents for drugs
with higher logP values. To mimic existing biological systems, lipid vesicles have previously been used as a method to uptake hydrophobic drugs, deliver them across cell
membranes, and release them with minimal cytotoxicity.11 However, lipids often suffer
from low uptake eﬀiciency and a very high critical aggregation concentration (CAC).12
CAC is a measure of the minimum concentration at which nanoparticles form from a
surfactant mixture. This implies that a high concentration of lipids must be employed
in applying these systems, which have additional shortcomings including high membrane
fluidity (causing high permeability) and low stability.
Creation of a TDD system is challenging, as in addition to toxicity concerns with
respect to the system, it requires a material that can house a suﬀicient quantity of drug
and prevent decomposition of the encapsulated drug. The system must also have a way
to be cleared from the body either with or without degradation, and the degraded system
must also not be cytotoxic. Any TDD system must also evade the reticuloendothelial
system (RES), resisting premature renal removal from the body.13 Steric stabilization of
nanoparticles is necessary to avoid both aggregation between particles and adsorption
onto plasma proteins or other blood components.14 The charge on the surface of the
nanoparticle also has a strong effect on circulation time and delivery eﬀicacy. A positive
surface charge facilitates endocytosis by interacting with the negatively charged surface
of the phospholipid bilayer.15
Depending on structure, TDD systems have the ability to carry multiple
payloads.16 This can allow simultaneous uptake and delivery of drugs and imaging
agents, allowing a single system to be used for both therapeutic and diagnostic purposes.
These systems are referred to as theranostics.17 In addition to the obvious advantage
of combining imaging and treatment into a single procedure, theranostics also has the
unique advantage of monitoring the localized distribution of a drug delivered with a
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nanoparticle, both allowing more accurate measures of eﬀicacy and furthering the aim of
personalized medicine.1 The application in which theranostics has delivered the greatest
promise is in the targeting of malignant neoplasms, commonly referred to as cancer.18

1.1.2 The Tumor Microenvironment
Particles between 10 nm - 200 nm in size tend to concentrate in tumors and
other inflamed areas, which is referred to as enhanced permeability and retention (EPR,
Fig. 1).2 This targeting route is referred to as passive targeting. Tumors are incapable of
delivering a suﬀicient blood supply to all cells in the tumor mass if the tumor is larger than
~2𝑚𝑚3 .19 They overcome this by releasing growth factors, increasing vascular growth
within the tumor.20 This results in disorganized, dilated blood vessels with wide gaps
between endothelial cells.

Figure 1: Diagram of enhanced permeability and retention. Adapted from Valetti et al. under CC BY 2.0

Intracellular pH within neoplasmic cells is ≤ 5.4, whereas extracellular pH ~ 6.4.14
This is due to increased glycolysis more than oxidative phosphorylation for energy production, resulting in an increased concentration of lactic acid, referred to as the Walburg
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Effect.21 This allows acid labile units to be utilized for selective release of drugs within
neoplasmic cells. This has been utilized in multiple manners. The most straightforward is
using particles with covalent linkages that are acid-labile, making the nanoparticle simply
fall apart once it reaches the tumor cell, releasing its payload. One of the most successful ways to accomplish this is the use of 2,3-dimethylmaleic anhydride.22 This species is
converted into a carboxylate at the extracellular tumor pH (~ 6.4). Another method uses
basic moieties with a pKa between physiological pH and tumor pH. The most common
moieties for this include sulfonamide, histidine, and tertiary amine groups.23–25
In addition to the unique attributes of the tumor microenvironment, it is also
desireable to trigger drug release using external stimuli, such as temperature, ultrasound, light, and magnetic fields, which can increase the eﬀicacy of nanoparticles in
drug delivery.26 In order to include multiple motifs within the same nanoparticle, it is
necessary to have a system that can be synthetically tailored. This can be done using
polymer chemistry, as there exist many monomer units that can be modified with specific functionality.27 The ability to either create statistical or block copolymers from these
units allows for fine-tuning of nanoparticle structure to obtain the desired properties.

1.2 Well-Defined Polymers for TDD
1.2.1 Different Ways Polymers Have Been Used in TDD
Polymers have a long history of application in drug delivery, be it in the form
of free polymer,28 nanocapsules,29–33 hydrogels,34,35 or nanoparticles (Fig. 2).36,37 These
polymers, or their aggregates, can interact with drug molecules either through conjugation
or encapsulation. Polymers with a size useful for EPR (30 nm - 200 nm) are quite
common, however they often have issues with toxicity or short circulation time.38 Several
polymeric TDD systems have already reached the market, including Doxil, a PEG-ylated
liposomal form of doxorubicin to treat a wide variety of cancers,39 and Lupron Depot,
a poly(lactide-co-glycoside) microsphere that slowly releases leuprolide acetate to treat
prostate cancer.40
4

Figure 2: Polymeric TDD systems. Adapted from Janssen et al. under CC BY-NC-SA 3.0
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The foremost concern when selecting polymers for TDD is the level of biocompatibility. This has several implications, including the degradation pathway of the polymer
(if it degrades at all), and methods of clearance.41 The most widely accepted model in
predicting the success of polymers as TDD systems is the Ringsdorf Model.42 This proposes that polymers for drug delivery should consist of three units attached to a polymer
backbone: a targeting moiety, a solubilizing group, and a drug attached to a biodegradable spacer. The targeting moiety usually entails a ligand which binds to a protein which
is overexpressed in cell membranes of diseased cells. The solubilizing group increases
bioavailibility, and allows the usage of higher logP drugs than Lipinski’s rule would predict.
Polymers can increase drug eﬀicacy through several mechanisms. As one of the
most common problems when identifying promising drug candidates is hydrophilicity,
the simplest and arguably most important mechanism is increasing hydrophilicity of otherwise hydrophobic drugs. In the simplest case, a drug is “PEG-ylated”, or conjugated
to PEG via a linker that is cleaved in-vivo. Nanocapsules and nanoparticles operate by
a similar mechanism, where both have a hydrophobic region that solubilizes the drug.
There must then be some mechanism to release the drug payload. The simplest way to
do so is to use a polymer with monomer units that can be enzymatically cleaved, such as
poly(lactide) (PLA) or poly(caprolactone) (PCL). Alternatively, the nanoparticles can
be stimuli-responsive, with pH, temperature, and competitive binding providing possible
ways to do so.43 This allows far more versatility in the design of polymeric TDD systems versus traditional lipid-based ones. This creates a combinatorial space of polymeric
systems. Polymeric systems have also been used to make drug release profiles linear,
changing dosage pattern from a burst dosage to a delayed release.44

1.2.2 Overview of “Controlled” Polymerizations
As is standard with biomedical applications, reproducibility in therapeutic eﬀicacy
is of prime importance when designing a biomedical system. This is partially due to the
necessity of creating quantitative structure-activity relationships. Unlike small molecules,
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most polymers are a statistical distribution of products rather than a single molecular
structure.45 It is desirable to use polymerization reactions that are well-controlled, creating a narrow distribution of products, referred to as having a low polydispersity index
(PDI). PDI is defined as 𝑀 𝑤/𝑀 𝑛, which are defined as:

∞

𝑀𝑤 =

∑𝑖=1 𝑁𝑖 𝑀𝑖2

𝑀𝑛 =

∑𝑖=1 𝑁𝑖 𝑀𝑖

∞

∑𝑖=1 𝑁𝑖 𝑀𝑖

(1)

∞

∞

∑𝑖=1 𝑁𝑖

(2)

Where 𝑁𝑖 represents the number of molecules with weight 𝑀𝑖 . 𝑀𝑛 is the standard
arithmetic mean, whereas 𝑀𝑤 is weighted to where larger molecules count more toward
the mean. It also follows that 𝑀 𝑤 > 𝑀 𝑛 and 𝑃 𝐷𝐼 > 1 in all cases. As opposed to
the exponential rate law of traditional radical polymerization, when the rate of initiation
is significantly faster than the rate of propagation, all chains grow at approximately the
same rate, referred to as living polymerization.[] In this case, molecular weight increases
linearly as a function of time. This implies if the reaction kinetics are known, the reaction
can be quenched at a certain timepoint to obtain a polymer with the desired molar mass.

ROP
The first method of controlled polymerization used in this research was ringopening polymerization (ROP). This is primarily due to poly(lactide) (PLA) and
poly(caprolactone) (PCL) having a strong literature precedent in TDD.46,47 ROP is
a chain-growth polymerization that starts with an initiator that can open the ring,
creating a nucleophilic terminus which can open additional rings in the propagation step,
as shown in Fig. ??. For PLA, this proceeds using an anionic initiator, but cationic and
radical ROP can also be performed on other cyclic monomers.48,49
Mechanism of PLA polymerization
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The driving force behind this reaction is entropic, due to the additional degrees
of rotation introduced by opening the ring, resulting in a negative Δ𝐺.50 Unlike radical
polymerization, uncontrolled branching by hydrogen abstraction cannot occur, giving rise
to the living character of this polymerization mechanism.51

RAFT
Reversible addition-fragmentation transfer (RAFT) polymerization uses initiators
and vinyl monomers present in traditional radical polymerization, but with the addition
of a dopant that equilibrates with propagating radical species.52 This dopant, most commonly a thiocarbonylthio compound, is known as a chain-transfer agent (CTA). RAFT
can be done on a wide variety of vinyl monomers, using common radical reagents for
initiation, such as peroxides and azo compounds. RAFT has several other advantages,
including the wide variety of polymer architectures accessible,53,54 tolerance of functional
groups in the monomer and/or solvent,55 and relatively low cost compared to other living
techniques.56
Figure 3 outlines the generally accepted mechanism for RAFT polymerization.
Once a small number of monomers have have been added to the initiator, the chain
radicals (𝑃𝑛• ) equilibrate with the CTA, which is followed with a second equilibrium step
which results in the R group leaving, known as pre-equilibrium or reversible chain transfer.
It is important that 𝑘𝑏𝑑 >> 𝑘−𝑏𝑑 , otherwise the polymerization will likely lose its living
character. Likewise, it is important that the radical form of the R-group is reactive enough
to re-initiate the polymerization, otherwise the polymerization will stop prematurely.
This represents the main practical challenge of RAFT, as the CTA/monomer pair must
be carefully chosen.57
Following this re-initiation is a fast equilibrium which gives RAFT its living character. If 𝑘𝑝 < 𝑘𝑎𝑑𝑑 , then both dormant (i.e. “trapped” by the CTA) and living chains
will grow at approximately the same rate, making them the same length at any given
time. This also enforces the importance of choosing the proper CTA/monomer pair, as
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Figure 3: General scheme of RAFT (top) and detailed mechanism (bottom)
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the Z group alters the reactivity of the C=S bond. Most RAFT reactions use an excess
•
of CTA relative to initiator, as having a low concentration of 𝑃𝑚
in solution, in addition

to a high number of trapped chains, minimizes the rate of termination.

Other Controlled Polymerization Techniques
In addition to RAFT and ROP, atom-transfer radical polymerization (ATRP),
anionic polymerization, and nitroxide-mediated polymerization (NMP) complete the list
of the most common controlled polymerizations. For the sake of completeness, it is worth
mentioning the reasons for excluding these mechanisms from consideration.
ATRP is arguably the second most prevalent living polymerization mechanism,
being useful for a wide variety of monomers without the diﬀiculty of selecting an appropriate CTA.58 However, ATRP uses a copper system, which is detrimental for biological
applications, and thus requires extensive purification.59 Chapter 3 outlines a polymerization done in aqueous solution, which ATRP has only recently been used for, and only
in a very specialized system.60 Anionic polymerization is controlled enough to be the
normal mechanism for the synthesis of analytical standards, mainly poly(styrene) and
poly(methylmethacrylate).61 However, this requires harsh reagents such as alkali metals
or strong bases, which severely limit compatible solvents and monomers Finally, NMP has
compatibility with aqueous solutions, but the creation of polymer architectures present
in Chapters 2 and 3 have not been reported in literature, likely due to impractical
synthetic protocols.

1.2.3 Advanced Polymer Architectures
As mentioned previously, one of the parameters that can be altered in polymeric
TDD systems is polymer topology. Various polymer topologies have been reported, which
can have differing physical properties even with the same chemical composition and molecular weight.62,63 Branched polymers are particularly desireable due to both a low-density
core that can complex to drug payloads, paired with end-groups which can be function-
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alized with a higher density of targeting ligands than linear polymers.26 One class of
branched polymer that has garnered particular interest in TDD is dendrimers. First synthesized by Tomalia in the 1980’s,64 dendrimers were hailed as the future of medicinal
chemistry, owing to their superb physiochemical properties. The etymology of dendrimer
comes from the greek word dendron, meaning tree. There are several nomenclature rules
that are specific to dendrimers. The degree of branching is defined as a generation, starting at zero for a single monomer unit grown from the core moiety. There are also the
possibility of half-generation dendrons, due to the orthogonal nature of dendrimer growth
(Eq. 3). The first reported dendrimer was poly(amidoamine) (PAMAM), which is a key
molecule in this work.
The expectations for dendrimer performance in drug delivery were based on
two priors. The first was the possibility for dendrimers being suﬀiciently large to take
advantage of EPR. The second was the branched structure of dendrons creating a
plethora of “pockets” to encapsulate drug molecules via noncovalent interactions.65
This results in increased uptake eﬀiciency relative to linear analogues, such as PAMAM
vs. poly(ethyleneimine).66
Unlike linear and hyperbranched polymers, there are no reported instances of onepot dendrimer synthesis.67 Dendrimers instead require a step-growth process, usually
with purification steps in between. There are also limits in terms of usable monomers. A
general scheme for this is outlined below:

𝐴𝐵𝑛 + 𝐷𝐸𝑛 ⟶ 𝐴(𝐶𝐸)𝑛

(3)

Where B is a group that will specifically react with D rather than A or E. This
can be viewed as an orthogonal synthesis, where the mass of the dendrimer increases by
a factor of 𝑛 during each synthetic step.
Two primary issues with dendrimers in TDD are insuﬀicient uptake and insuﬀicient
release of payload.68 Methods have been proposed to alleviate this problem, including the
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synthesis of stimuli-responsive dendrimers to facilitate release,69 cross linking and gelation
to more strongly incorporate drug payloads,70 and chemical functionalization to increase
bioavailibility.71 Another avenue that is orthogonal to the latter two is the synthesis
of amphiphilic dendrimers, which, similar to their linear block copolymer analogs, can
self-assemble into more complex morphologies.

1.3 Self-Assembly
1.3.1 Basics of Nanoparticle Formation
Polymer nanoparticles constructed from amphiphilic polymers can form multiple
morphologies, including micelles, vesicles, laminae, and tubes.72 The morphology of the
aggregate is most dependent on the ratio of hydrophobic and hydrophilic moieties.73
In accordance with like dissolves like, aqueous solvation of large hydrophobic molecules
is unfavorable, whereas Van der Waals forces allow hydrophobic molecules to solvate
each other. This often results in immiscible mixtures, where the hydrophobic portion
“crashes out” or emulsifies in the aqueous media. However, entropy facilitates spontaneous
assembly into supramolecular structures. Somewhat counter-intuitively, aggregation of
hydrophobic chains pushes water molecules out of solvation and into aqueous media,
increasing the entropy of the system. The amount of polymeric units necessary to selfassemble is referred to as the aggregation number (𝑁𝑎𝑔𝑔 ), and is strongly dependent on
the chemical structure of each polymer block, as well as solution concentration. There
have been heuristics established for the effect of hydrophobic to hydrophilic ratio on the
most stable morphology, most of which are derived from Israelachvelli theory.74 The most
widely used method to predict self-assembly is the surfactant packing parameter, 𝑁𝑠 :

𝑁𝑠 =

𝑉𝑐
𝑎𝑒 ∗ 𝐿𝑐

(4)

Here, 𝑉𝑐 is the volume of the hydrophobic chain, 𝑎𝑒 is the equilibrium area per
molecule at the aggregate interface, and 𝐿𝑐 is the length of the hydrophobic chains.
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𝑁𝑠 ≤ 1/3 predicts the formation of micelles, 1/3 < 𝑁𝑠 ≤ 1/2 predicts the formation
of worms, and 𝑁𝑠 > 1/2 are predicted to form bilayered vesicles. In other words, low
hydrophobic content results in a high curvature of the hydrophilic portion, resulting in the
formation of micelles. On the other end of the spectrum, a low-curvature system, resulting
from a large number of favorable Van der Waals interactions, results in a bilayered vesicle
morphology. It is important to note that this is purely a heuristic, and does not account
for more complex architectures including multi-layered (“onion”) vesicles,75 framboidal
vesicles,76 and jellyfish.77 Indeed, predicting vesicle morphology solely from hydrophobic
to hydrophilic ratio is an open problem, exemplified in the results shown in Chapter 2.
𝑁𝑠 does not account for the kinetics of particle formation, which result in several
experimental considerations, the first of which is the order of particle formation. Several
groups78,79 have determined that self-assembling amphiphilic polymers undergo a kinetic
pathway where micelles are formed, which elongate into tubes, and eventually pinch
off into vesicles. This corresponds to either additional material incorporating into the
nanoparticle or fusion of micelles. Worms are known to be the least mechanically stable
morphology,80 especially as they lengthen. This free energy penalty can be removed by
the polymer spontaneously folding into vesicles. This requires a suﬀicient amount of
material with a large enough hydrophobic core to aggregate into a bilayer, which ties
together the thermodynamic and kinetic considerations of vesicle formation.

1.3.2 Practical Considerations of Self-Assembly
Techniques used in nanoparticle preparation, including addition of ions, freezethaw-cycling, and filtration, will affect the size, morphology, and polydispersity of
vesicles.81 Polydispersity index (PDI) applies to both polymers and nanoparticles, and
corresponds to the variance of nanoparticle size. Unsurprisingly, highly monodisperse
polymers tend to lead to highly monodisperse nanoparticles, and vice-versa.

The

resulting aggregates can have their solution stability increased by cross-linking, either
using covalent or non-covalent methods.82 Covalent cross-linkers must be biodegradable
to be useful for drug delivery applications, making non-covalent cross-linking such
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as 𝜋 − 𝜋 stacking, stereocomplexation,83 or the fluorophilic effect84 a more versatile
technique to make solution-stable aggregates. Out of all the aggregates most commonly
formed from amphiphilic polymer systems, vesicles are known to have the highest
solution stability.85 More specifically, the balance of elasticity and toughness of their
bilayered membrane allows for deformation in response to aspiration and shearing
without rupturing and releasing the encapsulated payload. Vesicles also have the unique
advantage of encapsulating both hydrophilic and hydrophobic drugs, due to their
hydrophilic core and hydrophobic membrane.86
It is desirable to combine the aformentioned properties of dendrimers with the
uptake and mechanical properties of vesicles, which can be done by the synthesis of amphiphilic dendrimers. If a dendrimer consists of two or more distinct dendritic units, it is
then referred to as a “Janus Dendrimers”, named after the Roman god Janus due to their
two-faced nature.87 Scientists, including Percec, Tomailia, and Frechet, have constructed
Janus dendrimers that self-assemble into a wide array of morphologies.88–90 However,
there have been several noted shortcomings, with one of the most widely espoused being
synthetic diﬀiculty.

1.3.3 Hybrid Structures to Overcome Difficulties
As mentioned in the previous section, one of the major problems with dendrimers
is the high synthetic diﬀiculty compared to linear polymers. This is exacerbated when
working with amphiphilic systems, where the number of non-selective solvents for each
face is very small. Though a dendrimer with a perfect structure has a predictable molecular weight, the weight is quantized, effectively doubling each generation. If targeting
a specific hydrophobic/hydrophilic weight ratio, for reasons outlined in section 1.3, it
is preferable to have the ability to synthesize any molecular weight, rather than being
confined to those of each generation. This can be done with linear-dendritic block copolymers (LDBCs). LDBCs allow for the advantages of dendrimers to be used with far less
synthetic overhead, especially when working with amphiphilic systems. LDBCs can either
be synthesized by a “chain-first” or “dendron-first” method, depending on the chemical
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species used.91,92 Due again to the synthetic diﬀiculty of dendrons, the “dendron-first”
method remains the most popular. This is typically done by using the periphery of the
dendron as a macroinitiator for the polymerization of the linear portion.

1.4 Characterization Methods
1.4.1 Key Components of Polymer Characterization
Like small organic molecules, proton nuclear magnetic resonance (1 𝐻 NMR) is a
key method of characterizing polymers. Though peaks corresponding to polymer chains
are often quite broad due to a large number of intramolecular interactions,93 end-group
analysis is a simple way to determine 𝑀𝑛 . Here, the end-group is defined as either the
initiating or terminal group of a polymer. If the chemical shift of this end-group is
suﬀiciently different from that of the main chain, the end-group effectively serves as an
internal standard. Set the relative integration of the end-group, and then convert the
integration of main chain protons to the degree of polymerization (𝐷𝑃 ) of your molecule
depending on the monomer. If the end-group overlaps with the polymer, NMR will not
prove useful. Likewise, polymers often have solubility issues in common NMR solvents.
As mentioned earlier, NMR only gives 𝑀𝑛 . In order to get 𝑀𝑤 , gel permeation
chromatography (GPC) is the simplest method. GPC uses a porous stationary phase to
separate small molecules from large ones. Larger molecules are sterically incapable of
entering the pores, making them elute first, whereas small molecules explore these pores
as they pass through the column, eluting later. Depending on the range and magnitude
of pore sizes, different mass ranges can be separated. The most straightforward and
inexpensive way to determine molecular weight is to use a refractive index detector (RI)
with a calibration curve made from low-PDI standards. This allows retention time to be
translated into both 𝑀𝑛 and 𝑀𝑤 , as the full distribution of weights is obtained rather
than a number average obtained by NMR.
Several assumptions are made when using a calibration curve with an RI detector,
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the first of which being the analyte will interact with the stationary phase in a similar
manner compared to the external standard. Also, retention time more directly correlates
with hydrodynamic radius 𝑅ℎ than molar mass. Therefore, polymers are expected to
have a similar solvent interaction vs the standard. This does not account for the fact
that most standards are linear, and branched polymers will have a far lower 𝑅ℎ with
respect to molar mass. A potential fix for this is the use of multi-angle light scattering
(MALS), interchangeably referred to as static light scattering (SLS) as a method of absolute detection. This method requires off-line measurements of how the RI of the polymer
changes vs. concentration (which is solvent dependent), but can provide a more exact
measure of 𝑀𝑤 and the radius of gyration (𝑅𝑔 ). MALS works by irradiating the sample
with a laser beam, which is then scattered anisotropically by the sample. The intensity
of scattered light is then measured versus angle and concentration, expressed as follows:

1
1
𝐾𝑐
=(
+ 2𝐴2 𝑐) ×
𝑅(Θ, 𝑐)
𝑀𝑤
𝑃 (𝑞)

(5)

where 𝐾 is the optical constant, 𝑐 is the concentration, 𝑅(Θ, 𝑐) is the excess
Rayleigh ratio, Θ is the scattering angle, 𝑀𝑤 is the weight average molecular weight, 𝐴2
is the second virial coeﬀicient, 𝑃 (𝑞) is the form factor, and 𝑞 is the scattering vector. The
form factor has been calculated for several shapes.94,95 The second virial coeﬀicient measures the particle-particle and particle-solvent interactions, and also contains information
about the 𝑅𝑔 . A two-dimensional manifold of Eq. 5 plotted vs. angle is referred to as
a Zimm plot. If measurements are taken at several angles and concentrations, then the
zero-angle and zero-concentration scattering intensities can be extrapolated. The slope
of the line at 𝑐 → 0 is the radius of gyration, 𝑅𝑔 , and the intercept equals 1/𝑀𝑤 . For
a polymer of 𝑛 mass elements of masses 𝑚𝑖 , 𝑖 = 1, 2, 3...𝑛, located at fixed distances 𝑠𝑖
from the center of mass, 𝑅𝑔 is the square-root of the mass average of 𝑠2𝑖 over all mass
elements, i.e.
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𝑛

𝑛

𝑠 = (∑ 𝑚𝑖 𝑠2𝑖 / ∑ 𝑚𝑖 )1/2
𝑖=1

(6)

𝑖=1

The full derivation and information obtained by a Zimm plot is vast, and a rigorous explanation is available elsewhere for the interested reader.96 Additional detectors
common for GPC are viscometers and ultraviolet-visible (UV-Vis) detectors. The former
requires the Mark-Houwink parameter for the polymer to be known, but provides a universal calibration for molar mass.97 The latter requires that the polymers absorb light in
the UV-Vis region. These detectors do not warrant additional explanation for this body
of work, as these requirements are not met. Surprisingly, our previous work98 has found
that RI detection with a poly(styrene) calibration provides an accurate determination of
𝑀𝑛 when validated with both NMR and MALS, despite the branched portion of LDBCs.

1.4.2 Key Components of Nanoparticle Characterization
The most facile method of determining whether polymers self-assemble, and their
PDI if so, is dynamic light scattering (DLS). DLS correlates the diffusion of particles
through a medium to the size of the particle, 𝑅𝐻 . DLS can be coarsely defined as the
time-average of MALS at a single angle, where the speckle pattern of light scattered
is measured as a function of time.99 Smaller particles exhibit more random Brownian
motion over the measurement time domain (1 MHz) than larger ones, meaning that the
speckle image of smaller particles changes faster than that of larger ones.
As DLS only gives information regarding the size and dispersity of particles, additional methods of characterization are needed to determine morphology. The most
commonly employed method for this is microscopy. Though several variants are capable
of achieving the sub-micron resolution necessary for polymeric nanoparticles,100,101 transmission electron microscopy (TEM) provides high resolution images with sample prep
that is unlikely to perturb the morphology of the formed nanoparticles. TEM can be
thought of as a higher resolution variant of optical microscopy, given an electron beam
has a lower wavelength than visible light is capable of producing. When paired with a
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hydrophobic contrast agent, a differentiation can be made between micelles and vesicles.
Negative contrast agents are usually electron-dense species such as uranyl formate, which
result in dark portions of the image. If the species is micellular, the hydrophobic negative
contrast agent will concentrate toward the core of the micelle. With vesicles, it will form
a ring-like structure within the hydrophobic membrane with a bright core.
In order to determine the CAC of polymer nanoparticles, several methods have
been reported. Below the CAC, amphiphilic polymers tend to aggregate at the air-water
interface, with hydrophobic polymers sticking up out of solution.102 As more polymer is
added, the surface tension decreases. However, once the CAC is reached, the polymer
chains begin to aggregate in solution, and the surface tension no longer decreases as a
function of concentration. This requires a tensiometer for measurement. A more practical
method involves the use of fluorimetry or UV-Vis. The most commonly used method103
is to use pyrene as a probe, and perform a titration of polymer into solutions of pyrene
with a constant concentration. The fluorescence intensity of the third vibronic band of
pyrene at 383 nm increases drastically in nonpolar environments, allowing a great deal
of sensitivity with this probing method.104
Additional structural details can be derived from advanced scattering techniques,
including small-angle X-ray scattering (SAXS) and small-angle neutron scattering
(SANS). These techniques probe particles with nanometer sized inhomogeneities by
irradiating them and measuring the intensity of scattered photons at very small angles
(typically 0.1 − 10𝑜 ).105 This can be seen as MALS with a higher energy photon source.

1.5 Biological Imaging
1.5.1 Imaging Methods
One of the overarching goals of the research outlined in this thesis is to create
theranostics, which is a portmanteau of “therapeutic” and “diagnostic”. As the name
implies, theranostic agents simultaneously provide therapeutic effects and in-vivo imaging.
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For the project outlined in Chapter 2, this is approached by creating polymersomes
that can simultaneously encapsulate hydrophilic and hydrophobic molecules into a single
nanoparticle, meaning that a dye and drug molecule can be encapsulated into the same
molecule at the same time. Chapter 3 directly incorporates imaging agents into the
polymer backbone.
As with drugs, imaging probes also commonly exhibit solubility issues. This
issue has been addressed in a similar manner, with either uptake into polymer
nanoparticles106,107 or pegylation108 , which can allow probes to also take advantage of
the EPR effect. Following are two methods that are most relevant to this body of work.

Optical Imaging
One of the least invasive methods for imaging, that requires no radiation exposure,
is fluorescence microscopy. This involves the use of a fluorescent dye or quantum dot which
is applied in-vivo and excited by an external light source, with the emitted photon as the
signal for the image. This has the advantage of using non-ionizing radiation compared
to X-ray, PET or CT scans. Due to both autofluorescence of biological tissue and light
scattering by organelles, dyes with an absorbtion maximum between 650-1350 nm (NIR)
are most commonly usecd. Though resolution is continually improving due to advances
in microscopy109 and the synthesis of NIR dyes with large Stokes shifts,110,111 penetration
depth continues to be an issue.112 One imaging technique that fixes the penetration depth
issue, at the cost of resolution, is magnetic resonance imaging (MRI).113

Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is one of the more common diagnostic methods
used in oncology. This is typically done by using a contrast agent, which changes the
longitudal relaxation (𝑇1 ) of protons within tissues.114 This is most commonly done with
Gadolinium based contrast agents, which have recently come under scrutiny for concerns
regarding toxicity.115 In addition, inherent sources of noise from other protons within the
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body affect the signal-to-noise ratio (S/N) of traditional contrast agents. Alternatives to
traditional contrast agents is therefore an open area of research in medical imaging and
cell tracking.
In 2005, Ahrens et al. described the first example of using perfluorocarbons as
an MRI contrast agent.116 This resulted in both relatively high-resolution images, given
the low fluorine background in-vivo, and allowed complementary images to be gathered
with 1 𝐻 NMR. Due to the necessity of millimolar quantities of fluorine atoms, perfluoronated polymers have provided a promising route to MRI agents.117 One necessity in the
design of fluorinated MRI imaging systems is a suﬀiciently high translational relaxation
(𝑇2 ). Most fluorine systems have a 𝑇2 that is too low to be detected by traditional MRI
instrumentation.118 With respect to polymeric systems, chain mobility correlates highly
with a high 𝑇2 value. 𝑇2 has a negative correlation with 𝑇𝑔 , and a positive correlation
with molecular weight.119 Due to the fact most perfluoronated polymers are naturally
hydrophobic, there is an inherent trade-off between the weight percentage of fluorine
atoms and 𝑇2 .120 This effect is magnified in self-assembling polymeric systems, due to
hydrophobic interactions both limiting chain mobility and increasing dipole interactions,
decreasing 𝑇2 . Several researchers121,121,122 have created a polymeric TDD system with
2.5 wt% fluorine and a 𝑇2 of 54ms. Later research by the same group created a perfluorinated polymeric system with a mass ratio of fluorine as high as 25%, while still having
a 𝑇2 of 100ms.123

1.6 Conclusion
This work will outline several libraries of novel amphiphilic Janus-type LDBCs that
self assemble into a wide array of morphologies, with the long-term goal of utilization in
TDD systems. For a theranostic system, vesicles are the ideal morphology, due to the
ability to simultaneously uptake hydrophobic and hydrophilic molecules (be they imaging
or therapeutic agents). To this end, the effects of hydrophobic to hydrophilic mass ratio
were studied using the traditional route of synthesis followed by nanoparticle creation
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(Chapter 2) and in-situ studies of self-assembly (Chapter 3). The results of these
endeavors have created both more practical synthetic pathways to these novel systems,
and have created knowledge regarding the self-assembly of Janus-type LDBCs.
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CHAPTER 2: SYNTHESIS AND CHARACTERIZATION OF
POLYLACTIDE‐PAMAM “JANUS‐TYPE”
LINEAR‐DENDRITIC HYBRIDS

This chapter adapted from Chandrasiri, I. , Abebe, D. G., Gupta, S. , Williams,
J. S., Rieger, W. D., Simms, B. L., Yaddehige, M. L., Noh, Y. , Payne, M. E., Fortenberry, A. W., Smith, A. E., Ilavsky, J. , Grayson, S. M., Schneider, G. J. and Watkins,
D. L. (2019), Synthesis and characterization of polylactide‐PAMAM “Janus‐type” linear‐dendritic hybrids. J. Polym. Sci. Part A: Polym. Chem. doi:10.1002/pola.29409.
My specific contributions included early reaction optimization of PAMAM synthesis, synthesis of PAMAM-PLLA LDBCs, performing and analyzing TGA and DSC, performing
CAC measurements, performing portions of DLS data collection, and performing SAXS
at Argonne National Laboratory.

Abstract
Herein is presented a facile and comprehensive synthetic methodology for the
preparation of polyester-polyamidoamine (PAMAM) (i.e., polyester: polylactide [PLA]
(hydrophobic) and PAMAM (hydrophilic)) polymers. A library of PLA- PAMAM linear dendritic block copolymers (LDBCs) in which both L and D, L polylactide were
employed in mass ratios of 30:70, 50:50, 70:30, and 90:10 (PLA:PAMAM) were synthesized and analyzed. When placed in aqueous media, the immiscibility of the hydrophilic
and hydrophobic segments leads to nanophase-segregation exhibited as the formation of
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aggregates (e.g., vesicles, worms, and/or micelles). By employing both stereochemical
configurations of PLA, the differentiation in mass ratios of PLA-PAMAM aided in elucidating the structure–property relationships of the LDBC system and provided a means
toward the control of nanoparticle morphology. Transmission electron microscopy and
dynamic light scattering afford the size and shape of the nanoparticles with diameters
ranging from 10.6 for low mass ratios to 122.4 nm for high mass ratios of PLA-PAMAM
and positive 𝜁-potential values between +24.7 and +48.2 mV. Furthermore, small-angle
X-ray scattering (SAXS) studies were employed to obtain more detailed information on
the morphological assemblies constructed via direct dissolution. Such insights provide a
pathway toward nanomaterials with unique morphologies and tunable properties deemed
relevant in the development of next generation biomaterials.

2.1 Introduction
As described in Chapter 1, one of the most promising candidates in terms of polymeric systems for targeted drug delivery is linear-dendritic block copolymers (LDBCs).
This is due to the unique advantages of both blocks. In the case of dendrons, this includes
multiple endgroups and internal cavities for encapsulation of drug molecules.124,125 For
linear polymers, this includes monomer versatility, synthetic ease, and monomer-level
weight control in the case of polymers constructed using a living mechanism.126 This
work presents LDBCs comprised of PAMAM is a hydrophilic dendrimer comprised of an
amide backbone. Its structural cavities afford opportunities for encapsulation of small
molecules via noncovalent interactions,4 mainly hydrogen bonding. The terminal free
amine groups provide a positive-charge surface density suitable for biological applications (i.e., cell binding and endocytosis).15 Naturally, PAMAM has found wide interest
as a drug delivery vector and there is a large body of established work in terms of its
drug encapsulation, transfection eﬀiciency and delivery capacity.127
PAMAM is synthesized by alternating Michael addition89 and nucleophilic substitution. The Michael addition involves a free amine group reacting with the terminal
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position of methyl acrylate, followed by protonation to yield a half-generation (Gn.5) dendrimer with methyl esters as end groups. For a full generation (Gx.0) dendrimer, a large
excess of ethylenediamine is added, which displaces the methyl ester to create an amide
bond. This yields a dendrimer with amine terminal groups, in theory. In practice, care
must be taken to ensure the reaction does not result in backbiting, where two endgroups
are bridged together, creating a structural defect. The full generation dendrons are also
quite hydroscopic, often requiring high vacuum or lyophilization to fully dry.
In a review of the type of linear polymers utilized in LDBCs, a limited few have
been reported—those of which include poly(ethylene oxide), poly(2-methyl-2-oxazoline),
poly(styrene), and poly(propylene oxide). Most notable are those LDBCs created with
biodegradable and biocompatible polyesters, including polylactide (PLA). PLA is one
of the few hydrophobic polymers that can have its stereochemical structure modified
by polymerizing the _D_or L form of the monomer.34 It is also one of the most well
characterized and widely applied polymers for biomedical applications.
PLA is synthesized by ring-opening polymerization. The most common method
uses tin(II) 2-ethylhexanoate (𝑆𝑛(𝑂𝑐𝑡)2 ) as a Lewis acid catalyst, which coordinates to
the ester within the lactide ring. This makes the 𝛼-carbon of the lactide more electrophilic, facilitating attack by an alcohol. This also gives reason for the sensitivity of
this polymerization to water, as it is capable of initiating the polymerization. If done
with suﬀiciently pure reagents in an anhydrous environment, this results in very low-PDI
polymers. 𝑆𝑛(𝑂𝑐𝑡)2 is quite toxic, and polymerizing with this catalyst requires heat
(usually reflux in toluene). Therefore, there have been multiple efforts to develop milder
conditions using milder reagents.
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2.2 Results and Discussion
2.2.1 Design of Polyester-PAMAM LDBCs
An illustration of the PLA-PAMAM LDBCs of study is shown in Fig. 4. The
hydrophilic block which consists of dendritic PAMAM was chosen due to its synthetic
accessibility allowing a variety of functional groups to be readily incorporated. Possessing
a hyperbranched polymeric structure, the backbone of PAMAM mimics the polypeptide
nature of many biological species present in the body.128 Such a structure renders the
PAMAM portion more biocompatible than other traditional dendritic systems.
Opposite is the hydrophobic polyester block, either PLLA (L) or PDLLA (DL).
These hydrophobic polymer chains drive the self-assembly of the nanostructures. These
were systematically chosen for two purposes: (1) extended pedigree as biocompatible and
biodegradable biomaterials and (2) accessible range of thermal and mechanical properties (i.e. crystalline vs amorphous).83 By utilizing the 1:1 mixture of _D_and L-lactide
monomer, the heterotactic PDLLA is achieved. This polymer is amorphous and does not
exhibit a melting temperature (𝑇𝑚 ). Alternatively, the pure L-lactide monomer yields
the isotactic PLLA which is semi-crystalline possessing a 𝑇𝑚 above 180 degrees.129 The
differences between crystalline PLLA and amorphous PDLLA provided an opportunity
to probe the effects of monomer composition on the morphology and thermodynamic
properties of the resulting self-assembled nanostructure.
The LDBCs in this study are named by the weight percentage of PLA, followed
by the stereochemistry of the PLA monomer, followed by the generation of PAMAM,
and finally the end-groups which are assumed to be 𝑁 𝐻 + if not explicitly defined. For
example, an LDBC that is 70 % PLLA by mass relative to G3 PAMAM would be named
70-L-G3, while the tert-butyl carbonate (Boc) protected G3 PAMAM that has equal mass
relative to PDLLA would be referred to as 50-DL-G3-Boc. The general structure of these
LDBCs is given in Fig. 4.
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Figure 4: General Structure of PAMAM-PLA LDBCs

2.2.2 Synthesis
The general synthesis of L-G3 and DL-G3 is depicted in Fig. 5 and 6. Boc protected PAMAM (G3) possessing a hydroxyl focal-point was synthesized in five steps and
used as the macroinitiator (HO-G3Boc) for ROP of either L- or DL-lactide monomer to
yield LDBC precursors, L-G3Boc and DL-G3Boc in mass ratios of 90:10, 70:30, 50:50 and
30:70 polyester to PAMAM. Under mild conditions, the Boc protecting group is readily
removed using TFA to yield the target LDBCs, L-G3 and DL-G3 (Fig. 6). While others
have been limited to <50 weight % hydrophobic content in order to form stable aqueous
nanoparticles,124 the amine protection/de-protection approach utilized here allowed us
to prepare copolymers containing up to 90 weight % hydrophobic polymer while still
possessing enough hydrophilic character to self-assemble into stable nanostructures in
aqueous solution.
In employing a dendrimer first approach, (Fig. 6) characterization of the macroinitatior, HO-G3Boc, is critical. The Boc group was installed to prevent ROP off of the
terminal amines and additional side reactions at the periphery of the PAMAM dendron.
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Figure 5: Synthesis of Boc-protected LDBC precursors
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Figure 6: ROP and Deprotection
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MALDI-TOF mass spectrometry was used to validate the structural integrity of the PAMAM dendron and reactivity of the hydroxyl focal-point as steric inhibition has been a
reported challenge for the synthesis of LDBCs.125 For the latter, HO-G3Boc exhibiting
a mass to charge ratio of 2481 m/z [𝑀 + 𝑁 𝑎]+ was treated with acetic anhydride (Appendix A, Fig. 39). The product was purified and analyzed via mass spectrometry to
reveal a difference in mass of 42 m/z corresponding to the addition of an acyl group at
the focal-point and sole reactivity of the hydroxyl group on HO-G3Boc.
Verification by both 1 𝐻 NMR spectroscopy (Fig. 32) and mass spectrometry (Fig.
38) supported further use of HO-G3Boc in ROP of L- and DL-lactide. Reactions were
conducted with DBU as the catalyst in anhydrous chloroform and purified via precipitation in a mixture of diethylether, hexane and methanol (15:5:1). It is imperative to note
that the ROP step was optimized for DBU as the catalyst, rather than the traditional
𝑆𝑛(𝑂𝑐𝑡)2 .130 During synthesis development, the concentration of 𝑆𝑛(𝑂𝑐𝑡)2 required to
achieve >90% monomer conversion was much higher, particularly at higher PAMAM
weight percentages, than the 5% (per hydroxyl initiator) previously reported.131 We observed a mere 8% monomer conversion for our copolymers with 5% catalyst loading and
required ~20% 𝑆𝑛(𝑂𝑐𝑡)2 to reach monomer conversion >90%. When the polyester weight
percentage is higher, e.g. 70:30, slightly less 𝑆𝑛(𝑂𝑐𝑡2 ) is required (~15%) to drive lactide
monomer conversion to > 90%. Rationale for such high loading of 𝑆𝑛(𝑂𝑐𝑡)2 are not
fully understood; however, it is feasible to assume catalyst deactivation or sequestration
through interactions with the PAMAM macroinitiator is the cause. Polymerization kinetic studies are actively on-going with the focus on understanding initiation, propagation
and competing events such as depolymerization and catalyst deactivation. Because the
higher loading of a potentially toxic metal catalyst is counter-productive to the biomedical aim of this study, a number of other organometallic (zinc undecylenate) and organic
(4-dimethylaminopyridine, DBU, and triazabicyclodecene) catalyst systems previously
reported for ROP of lactides were screened. DBU was found to be the most eﬀicient
catalyst, leading to near quantitative monomer conversion at all weight percentages investigated. In addition, the use of DBU afforded further advantages, such as reduced
29

reaction time (4 hour), mild reaction conditions (25𝑜 𝐶), and quantitative removal of the
resulting DBU-benzoate salt which eliminates the presence of residual cytotoxic catalyst
within the polymer.
As shown in Fig. 7 an overlay of NMR spectra shows characteristic peaks of PAMAM (2.33 - 3.6 ppm) and polylactide (1.57, 5.22 ppm). Both segments are present in
the spectrum of the coupled product for precursor 70-DL-G3-Boc where 70 denotes the
percentage of DL-lactide composing the LDBCs (Fig. 7b). Boc-protected LDBCs show
high solubility in common solvents such as chloroform and THF; however, upon deprotection of the PAMAM block with TFA to yield 70-DL-G3, organic solubility dramatically
decreased due to the formation of 𝑁 𝐻3+ terminal groups. NMR spectra of deprotected
70-DL-G3 (Fig. 7c; chloroform-d) give indirect evidence of solvent-driven aggregation
by the disappearance of resonance peaks for PAMAM, while polylactide peaks remain
visible. No precipitation is observed in the chloroform-d solution, which suggests the
formation of a reverse-micelle where PAMAM is shielded from the solvent (i.e, micelle
core) and PDLLA acts as a stabilized shell. Such analyses have been reported by others
to give indirect confirmation of a covalently linked copolymer with both hydrophilic and
hydrophobic components.132

2.2.3 Molecular Weight Analysis of LDBCs
Aiming to correlate feed ratios to that of molecular weight and degree of polymerization, further characterization of the products was required. The Boc-protected precursors were studied due to the limited solubility of the deprotected LBDCs and tabulation
of the results are given in Table 1 and molecular weight calculations giving theoretical
molecular weights (𝑀𝑡ℎ ) are given in Appendix A, Table 8. Initially, MALDI and GPC
presented a unique challenge for these systems. In the case of MALDI, ionization of the
PAMAM species only occurred in a small subset of solvent/matrix combinations that
were tested. Such challenges have been noted in the literature.133 In contrast, GPC gave
better results particularly for precursors with a greater mass percentage of polylactide
(i.e., 90-DL-G3Boc, 70-DL-G3Boc, 90-L-G3Boc and 70-L-G3Boc). As the calibration
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Figure 7: Stacked NMR indicating successful deprotection

curve was created with a linear polystyrene standard, the hydrodynamic volume of these
polymers did not correlate perfectly, as dendrons are more compact. For LDBCs with
a greater linear (i.e., polylactide) portion, the peaks displayed a more Gaussian nature,
whereas in systems that had a higher weight percentage dendritic portion (i.e., 50-DLG3Boc, 30-DL-G3Boc, 50-L-G3Boc and 30-L-G3Boc), there was a deviation from the
normal distribution, with shoulders appearing adjacent to the major peak (Appendix A,
Fig. 37). Upon changing the solvent from THF to DMF, an improved chromatographic
behavior is seen presumably due to increased solubility of LDBCs with higher PAMAM
ratios in the more polar solvent.
Table 1: Molecular weight analysis of PAMAM-PLA LDBCs by 1 𝐻 NMR and GPC.

𝑀𝑛

𝑀𝑛

𝑀𝑤

PDI

𝑀𝑛

𝑀𝑤

PDI

Sample

Yield

(NMR) 𝑀𝑡ℎ

(THF) (THF) (THF) (DMF) (DMF) (DMF)

90-L-G3-

94%

20,028 17,465

12,084 20,659

BOC
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1.71

13,259 19,043

1.44

𝑀𝑛

𝑀𝑛

𝑀𝑤

PDI

𝑀𝑛

𝑀𝑤

PDI

Sample

Yield

(NMR) 𝑀𝑡ℎ

(THF) (THF) (THF) (DMF) (DMF) (DMF)

70-L-G3-

91%

6,564

6350

8,189

12,012

1.52

7,470

10,988

1.47

86%

3,902

4127

5,205

6,565

1.28

2,360

3,681

1.55

84%

2,892

3175

3,862

4,248

1.1

1,823

2,088

1.45

92%

20,964 17,465

15,303 24,203

1.58

18,053 22,756

1.47

87%

6,852

6350

8,255

11,688

1.47

7,198

10,415

1.44

87%

4,044

4127

5,540

6,972

1.28

2,430

3,904

1.6

83%

2,964

3175

4,402

4,941

1.13

1,912

2,207

1.15

BOC
50-L-G3BOC
30-L-G3BOC
90-DLG3-BOC
70-DLG3-BOC
50-DLG3-BOC
30-DLG3-BOC
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2.2.4 Thermal Analysis

Figure 8: TGA of PLLA (left) and PDLLA (right)

Thermal analysis via TGA (Fig. 8) and DSC (Fig. 9) was achieved using deprotected LDBCs. In this case, all polymers have 𝑁 𝐻3+ end groups, unless otherwise noted.
The amine end groups are expected to have some effect on thermal stability due to the
possibility of intramolecular hydrolysis or hydrogen bonding. Thermal stability followed
the general trend of increasing as the total molecular weight increased (Table 2). LDBC
90-L-G3 exhibits a higher decomposition temperature than that of 90-DL-G3 presumed
due to its crystalline nature.44 The one exception was 30-L-G3, which displayed an increase in thermal stability versus 50-L-G3. All L-G3 LDBCs except 90-L-G3 showed a
slight decrease in thermal stability before the decomposition point, which is hypothesized
to be due to the more hydroscopic nature of these LDBCs.
Glass transition temperature (𝑇𝑔 ) changed as a function of polyester type and hydrophobic mass ratio. LDBCs 90-L-G3 (57.7𝑜 𝐶) and 90-DL-G3 (52.3𝑜 𝐶) exhibit thermal
features that are more representative of polylactide while that of 30-L-G3 (39.4𝑜 𝐶) and
30-DL-G3 (32.6𝑜 𝐶) correspond to that of PAMAM (Table 2). These results are reasonable as both LDBC sets are comprised of majority polylactide or PAMAM, respectively.
Polymers 70-DL-G3 (39.4, 50.4𝑜 𝐶), 50-DL-G3 (36.5, 46.7𝑜 𝐶) and 70-L-G3 (41.2, 53.7𝑜 𝐶),
50-L-G3 (broad $~39.6^oC) exhibited multiple 𝑇𝑔 . By comparing the thermograms in
Fig.9 it appears that 70 and 50 % hydrophobic derivatives likely have similar volume
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Figure 9: DSC of PLLA (left) and PDLLA (right)

between the hydrophilic and hydrophobic regions, resulting in contributions from both
polymers being observable at the 𝑇𝑔 .134
Table 2: TGA and DSC results for LDBCs

LDBC

95% Decomp. (𝑜 𝐶)

𝑇𝑔 (𝑜 𝐶)

G3-PAMAM-Boc

51.81

G3-PAMAM

41.32

90-L-G3

208.8

57.66

70-L-G3

173.28

41.24, 53.66

50-L-G3

136.54

39.58

30-L-G3

182.91

39.37

90-DL-G3

194.19

52.35

70-DL-G3

193.52

39.42, 50.42

50-DL-G3

185.02

36.1, 46.7

30-DL-G3

167.27

32.6
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2.2.5 Self-Assembly and Morphology
Direct dissolution resulted in nanoparticles for LDBCs up to a 70-30 hydrophobichydrophilic mass ratio. Re-dispersion in water from the dry state was almost instantaneous, requiring little to no agitation. This observation is consistent with the variations in
hydrophilic character of the PAMAM dendron used in previous studies135 where the ionic
nature of the terminal amines for L-G3 and DL-G3 (𝑁 𝐻3+ ) increases their hydrophilic
character. When considering the potential future of our target materials and their pharmaceutical properties, this near instantaneous re-dispersion ability has both logistical
and application advantages.

Figure 10: TEM images utilizing uranyl formate as a contrast agent for a. 70-L-G3, b. 50-L-G3, c. 30-L-G3,
d. 70-DL-G3, e. 50-DL-G3, and f 30-DL-G3

To understand the morphology of the self-assembled nanoparticles, TEM analysis
was conducted. Additionally, the TEM observations are further confirmed by SAXS
analysis (vide infra). TEM captured aggregate morphologies of sizes (radii) ranging from
4.8 - 10.4 nm (Fig. 10). Uranyl formate was used as a stain to increase the contrast
between the hydrophilic and hydrophobic portions. LDBC 70-L-G3 shows a distribution
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of bilayered vesicles and elongated worm-like particles (Appendix A, Fig. 46). 50-L-G3
produces bilayered vesicles with radii ranging from 4.8 - 6.1 nm. 30-L-G3 yields core-shell
micelles with 7.1 nm radius. In comparison with 70-L-G3, 70-DL-G3 showed bilayered
vesicles, but no elongated worm like particles were observed. 50-DL-G3 yields bilayered
vesicles, and 30-DL-G3 produces core-shell micelles with the radii of 6.0 nm and 5.3 nm
respectively.
The formation of stable bilayered vesicles is an interesting achievement given the
molecular weight of the PLA blocks is relatively low. Previously reported vesicles composed of block copolymers of PLA, e.g. PEG-PLLA required considerably higher molecular weights compared to our oligomeric sizes and hydrophobic weight percentages.136
Comparable hydrodynamic volumes were determined via DLS (Table 3, Figs. 4045) with 𝜁 potentials ranging from +24.7 to +48.2 mV for nanoparticles prepared via
direct dissolution. Such values of +20-30 mV are viewed as highly stable and are common in drug delivery literature.99 The critical aggregation concentrations (CAC) for the
LDBCs ranged from 0.91 to 9.75 mg/L (Table 4, Appendix A, Figures 52 and 53) providing further evidence of stable nanoparticles.137 The values are comparable to those found
in literature and correlate to the candidacy of the copolymers as potential biomaterials.
Specifically, the CAC is dependant on the length and weight percentage of PLA, where
an increase in hydrophobicity is shown to lead to a significant decrease in the CAC value.
Table 3: DLS and Zeta potential results for LDBCs

Diameter

Diameter

𝜁-potential

Sample

(nm, TEM)

(nm, DLS)

PDI(DLS)

(mV)

Morphology

B: 70-L

20.8

122.4

0.18

54.9

Mixture
(worms and
vesicles)

C: 50-L

12.3

24.2

0.463

51.0

Bilayered
vesicles
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Diameter

Diameter

𝜁-potential

Sample

(nm, TEM)

(nm, DLS)

PDI(DLS)

(mV)

Morphology

D: 30-L

14.2

15.6

0.467

32.5

Core shell
micelle

F: 70-DL

19.2

21

0.212

12.8

Bilayered
vesicles

G: 50-DL

12.06

18

0.328

18.2; 24.9

Bilayered
vesicles

H: 30-DL

10.6

18

0.57

19.5

Core shell
micelle

Concerning, however, are the high 𝜁 potentials for nanoparticles formed from 50L-G3 and 50-DL-G3. There are conflicting reports regarding the ideal surface charge required for nanoparticle-assisted drug delivery.138,139 He et al. revealed that particles with
less than 15 mV surface charges exhibited ideal properties such as reduced macrophage
uptake, longer circulation time and higher tumor retention.140 However, it is well established that the charge effect of cell-uptake is cell type and surface charge dependent.139,141
For this study, the positively charged nanoparticles would penetrate into the cells more
easily as the electronic potential of cell membranes are generally known to be negative.142
Nonetheless, high cytotoxicity due to the presence of extremely compact amino groups
at the periphery of dendrimer structures like that of PAMAM have been well cited.143,144
Considering the size distribution and surface characteristics of nanoparticles in this study,
it should be noted that the surface properties of the nanostructures herein will not only
determine the uptake eﬀiciency of these materials but may also lead to severe drawbacks for future biological application. Therefore, surface modification will be needed
to minimize the positively charged surface comprised of PAMAM. Reducing the surface
charge will aid to avoid any impending cytotoxic effects while maintaining potential as
nanotherapeutics.
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Table 4: CAC data for LDBC series

LDBC

CAC (mg/L)

70-L-G3

1.82 ± 0.49

50-L-G3

6.59 ± 1.14

30-L-G3

9.75 ± 3.07

70-DL-G3

0.91 ± 0.23

50-DL-G3

1.41 ± 0.30

30-DL-G3

9.31 ± 3.57

By employing both stereochemical configurations of PLA, unique variations in
thermal properties as well as morphology are expected. Any differences in morphology
are a direct result of the varying stereoisomers of lactide (i.e. L vs DL) leading to diverse
morphologies according to crystallinity and chain mobility.145 Effects of the polyester type
are apparent when comparing the CAC and hydrodynamic volumes for L-G3 and DL-G3
as the more amorphous PDLLA-PAMAM LDBCs tend to have smaller CAC values and
radii.146
However, these differences are minimal. The isomeric features of PLA are more
evident for 90-L-G3 and 90-DL-G3. LDBCs with >70 % PLA were prepared through the
conventional nanoprecipitation method as direct dissolution in water was not possible
due to the greater hydrophobic content. 90-L-G3 produces nanostructures which are
kinetically “frozen” in intermediate (transition) states between worms, dumbbells and
spheres (vesicles). In Fig. 11a(inset), a spherical bud formation is observed in which a
segment of a worm-like aggregate appears to separate off into a vesicle.147 In contrast,
90-DL-G3 leads to the formation of predominately spherical nanostructures (vesicles),
while transient structures are not observed (Fig. 11c-d). When considering molecular
thermodynamic effects, equilibration through chain-exchange is not likely, due to the large
interfacial tension between the PLA and water. Also, the nanoparticles were prepared at
below the glass transition temperature of PLA (~52−54𝑜 𝐶). Noack et al. have postulated
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Figure 11: TEM of a,b. 90-L-G3, d,e 90-DL-G3. Nanoparticles were formed via nanoprecipitation rather than
direct dissolution.
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the crystallization of the PLLA hydrophobic block following microphase separation in
a selective solvent lead to destabilization of spherical particles which fuse with other
spherical micelles to grow into worm-like aggregates.148 In addition to the morphologies
presented in Figures 4 and 5, elongated micelles, cubes, and tube-like nanostructures have
been observed for these PLLA-PAMAM and PDLLA-PAMAM LDBCs under varying
conditions. This work is currently on-going with efforts towards understanding the selfassembly mechanism using both computational modelling and analytical characterization.

2.2.6 SAXS Analysis
To study the morphology more in detail, SAXS experiments on the nanoparticles
formed via direct dissolution were performed. An important goal in these studies was
to determine bilayer thickness in our vesicles, especially with respect to LDBCs. The
thickness of the vesicle wall strongly affects the size and stability of vesicles, and this
thickness is primarily determined by the hydrophobic portion.149–151 Polymer vesicles have
also been shown to be able to adopt a multi-walled “onion” morphology with multiple
alternating hydrophilic and hydrophobic regions.152 This is unlikely to be observed by
traditional microscopy methods and must be observed with SAXS (Fig. 12, Table 5).
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Table 5: SAXS, TEM and DLS data for PAMAM-PLA LDBCs normalized by volume fraction

𝑅𝑐𝑜𝑟𝑒

𝑅𝑡𝑜𝑡

SAXS

(SAXS)

(SAXS)

LCBC

model

(nm)

(nm)

70-L-

Core-

2.8 ±

10.2 ±

G3

shell

0.01

0.2

𝑅𝐻
PD

𝑅𝑇 𝐸𝑀

(SAXS) (nm)
30

10.4 ±

(DLS)

PD

𝑃 𝐷𝑇 𝐸𝑀

(nm)

(DLS)

24 ± 1

61.2 ±

48,

35, 25.3

26

0.1

vesicle

±3

50-L-

Core-

1.4 ±

7.3 ±

G3

shell

0.01

0.3

25

6.1 ±

23 ± 1

12.1 ±

28,

4, 9.5 ± 20

0.1

1

vesicle
30-L-

Core-

0.8 ±

7.2 ±

G3

shell

0.01

0.1

20

7.1 ±

30 ± 2

0.1

7.8 ± 1, 21,
6.7 ±

micelle

28

0.5

70-DL-

Core-

1.7 ±

8.6 ±

G3

shell

0.10

0.3

21

9.6 ±

21 ± 1

0.1

10.5 ±

31,

3, 7.6 ± 22

vesicle

0.3

50-DL-

Core-

3.2 ±

5.8 ±

G3

shell

0.01

0.1

33

6.0 ±

24 ± 1

0.1

9.0 ± 2, 30,
5.8 ± 1

25

vesicle
30-DL-

Core-

1.3 ±

7.4 ±

G3

shell

0.01

0.2

18

5.3 ±
0.1

micelle
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22 ± 1

9.0 ± 2, 25,
5.8 ± 1

25

To describe SAXS data for micelles, we used a core-shell model:94,95

𝑑Σ
Φ
𝑏
[𝐼
(𝑄) + 𝐼𝑠ℎ𝑒𝑙𝑙
(𝑄) + 𝐼𝐼𝑖𝑛𝑡𝑒𝑟 (𝑄) + 𝐼𝑏𝑙𝑜𝑏 (𝑄)]
=
𝑑Ω
𝑁𝑎𝑔𝑔 𝑉𝑚 𝑐𝑜𝑟𝑒
Here,

𝑑Σ
𝑑Ω

(7)

is the macroscopic scattering cross section, 𝜙 is the volume fraction of scatterers,

𝑄 is the momentum transfer, and 𝑉𝑚 is the total micellar volume of the block copolymer.
For 𝑁𝑎𝑔𝑔 , defined as the aggregation number or the number of chains attached to the
core, Eq. 8 corresponds to the scattering from the core, with 𝑣𝑐𝑜𝑟𝑒 as the volume of the
core block copolymer (PLA).

2
2
2
𝐼𝑐𝑜𝑟𝑒 (𝑄) = 𝑁𝑎𝑔𝑔
Δ𝜌𝑐𝑜𝑟𝑒
𝑣𝑐𝑜𝑟𝑒
𝐴𝑐𝑜𝑟𝑒 (𝑄)2

(8)

The core contrast with respect to the solvent is given by their respective X-ray
scattering length densities (XSLD) Δ𝜌𝑐𝑜𝑟𝑒 = 𝜌𝑐𝑜𝑟𝑒 − 𝜌𝑠𝑜𝑙𝑣𝑒𝑛𝑡 .

𝑏
2
2
𝐼𝑠ℎ𝑒𝑙𝑙
(𝑄) = 𝑁𝑎𝑔𝑔 ∗ (𝑁𝑎𝑔𝑔 − 𝐵𝑐𝑜𝑟𝑟 ) ∗ 𝑣𝑠ℎ𝑒𝑙𝑙
∗ Δ𝜌𝑠ℎ𝑒𝑙𝑙
∗ 𝐴2𝑠ℎ𝑒𝑙𝑙 (𝑄)2

(9)

Eq. 9 describes the scattering of the corona (PAMAM block), with 𝑣𝑠ℎ𝑒𝑙𝑙 , the
volume of the shell copolymer and Δ𝜌𝑠ℎ𝑒𝑙𝑙 = 𝜌𝑠ℎ𝑒𝑙𝑙 − 𝜌𝑠𝑜𝑙𝑣𝑒𝑛𝑡 .

2
𝐼𝐼𝑖𝑛𝑡𝑒𝑟 (𝑄) = 2Δ𝜌𝑐𝑜𝑟𝑒 ∗ Δ𝜌𝑠ℎ𝑒𝑙𝑙 𝑁𝑎𝑔𝑔
∗ 𝑉𝑐𝑜𝑟𝑒 ∗ 𝑉𝑠ℎ𝑒𝑙𝑙 ∗ 𝐴𝑐𝑜𝑟𝑒 (𝑄) ∗ 𝐴𝑠ℎ𝑒𝑙𝑙 (𝑄)

(10)

The third term, eq. 10, is due to interference between the core and corona.
The blob scattering from the swollen corona is implemented following Svaneborg and
Pedersen153 as:

2
2
𝐼𝑏𝑙𝑜𝑏 (𝑄) = 𝑉𝑠ℎ𝑒𝑙𝑙
Δ𝜌𝑠ℎ𝑒𝑙𝑙
∗
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𝑃 (𝑄)𝑐ℎ𝑎𝑖𝑛
(1 + 𝜈𝑃
̂ (𝑄)𝑐ℎ𝑎𝑖𝑛 )

(11)

Here, 𝐴𝑐𝑜𝑟𝑒 (𝑄) and 𝐴𝑠ℎ𝑒𝑙𝑙 (𝑄) are the scattering amplitudes of the core (PlA) and
shell (PAMAM) blocks, respectively.The interactions between the chains in the shell is
given by the blob correlation parameter, 𝐵𝑐𝑜𝑟𝑟 = 1/(1 + 𝜈),
̂ where 𝜈 ̂ is an effective virial
type parameter that scales with chain concentration in the shell.153 The corresponding
polydispersity index, p, for the micelles is calculated from the Gaussian distribution of
the micellar corona, 𝜎𝑚 , which defines the relative width of micellar surface at the micellesolvent interface.94,95
In the case of vesicles, the form factor is given by:154

𝑑Σ
𝜙
3𝑉
Δ𝜌
𝑗 (𝑄𝑅𝑐𝑜𝑟𝑒 ) 3𝑉𝑐𝑜𝑟𝑒 Δ𝜌𝑠ℎ𝑒𝑙𝑙 𝑗1 (𝑄𝑅𝑡𝑜𝑡 )
(𝑄) =
[ 𝑐𝑜𝑟𝑒 𝑠ℎ𝑒𝑙𝑙 1
+
]
𝑑Ω
𝑉𝑠ℎ𝑒𝑙𝑙
𝑄𝑅𝑐𝑜𝑟𝑒
𝑄𝑅𝑡𝑜𝑡

(12)

where 𝑉𝑐𝑜𝑟𝑒 , 𝑉𝑠ℎ𝑒𝑙𝑙 , and 𝑉𝑡𝑜𝑡 are the core, shell, and total volumes, respectively.
The shell thickness is given by 𝑅𝑡𝑜𝑡 − 𝑅𝑐𝑜𝑟𝑒 , with 𝑅𝑐𝑜𝑟𝑒 , the radius of the core and 𝑅𝑡𝑜𝑡 ,
the outer radius of the shell. The polydispersity is modeled following the size distribution
from TEM, which is compatible with Gaussian and log-normal distribution functions.105
The X-ray scattering length densities of the core and solvent are identical, whereas 𝑗1 is
the spherical Bessel function:

𝑗1 (𝑄𝑅𝑡𝑜𝑡 ) =

𝑠𝑖𝑛(𝑄𝑅𝑡𝑜𝑡 ) − 𝑄𝑅𝑡𝑜𝑡 ∗ 𝑐𝑜𝑠(𝑄𝑅𝑡𝑜𝑡 )
(𝑄𝑅𝑡𝑜𝑡 )2

(13)

Fig. 12 represents the scattering intensity normalized by volume fraction, 𝜙. The
data modelling was performed based on the TEM images. For LDBCs 70-L-G3, 50-L-G3,
70-DL-G3, and 50-L-G3, the TEM images depict vesicle like spherical structures in Fig.
10. The corresponding SAXS data was modelled using vesicle form factor as described in
Eq. 12. In the case of 70-L-G3, from TEM images, although some wormlike arrangements
of vesicles are observed, the spherical vesicle structure is statistically more dominant from
the scattering measurements. The high Q scaling behavior of ~ 𝑄−4 further supports the
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scattering from a smooth surface. LDBCs 30-DL-G3 and 30-L-G3 TEM images depict
spherical micellar structures. The shell thickness (𝑅𝑡𝑜𝑡 −𝑅𝑐𝑜𝑟𝑒 ) for the vesicles in 70-L-G3
and 50-L-G3 and DL-G3 systems represents the membrane thickness.

Figure 12: SAXS data from different PLA-PAMAM macromolecules normalized by their volume fraction . The
data are modeled (solid lines) using core-shell sphere, core-shell cylinder, (Eq. 7), and vesicle form factors
(Eq. 12)

2.3 Conclusion
In this work, a feasible synthetic strategy has been developed to afford LDBCs
that are composed of PAMAM and PLA. These materials are made with a high percent
conversion (83% - 94%) indicating an ease in the synthetic route taken for a series of
copolymers capable of self-assembly at varying hydrophobic ratios. By only modifying
the degree of polymerization of the hydrophobic portion, we were able to obtain multiple
morphologies and sizes from the same reaction mechanism. Direct dissolution provides a
facile and biocompatible methodology of nanoparticle preparation for these copolymers,
resulting in nanoparticles bearing positive surface charges. Thermal analysis shows that
the behavior of these LDBCs represents a combination of both polymeric segments. The
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details of the morphology were elucidated by TEM and SAXS, confirming these polymers
exhibited selective self-assembly into the desired morphology of vesicles and core-shell
micelles.
Advancing this study towards therapeutic drug delivery, reducing the surface
charge will be done to avoid impending cytotoxic effects while maintaining the potential
of the nanostructure as carriers. Within this scope, bilayer vesicles will be of particular interest due to their biomimetic nature which provides increased biocompatibility,
while also serving as a dual-purpose drug carrier for the simultaneous delivery of both
hydrophobic and/or hydrophilic drugs.155
In summary, the current work provides a suitable foundation for understanding
how the chemical make-up of the LDBC affects the overall self-assembled structure. Ongoing research is aimed towards developing structure-property relationships, surface modification and exploitation of beneficial structural properties for future applications.

2.4 Experimental
2.4.1 Materials
Reagents and solvents were purchased from commercial sources and used without further purification unless otherwise specified. THF and DMF were degassed in
20 L drums and passed through two sequential purification columns (activated alumina;
molecular sieves for DMF) under a positive argon atmosphere. All synthetic procedures
were carried out under argon atmosphere using standard Schlenk line techniques unless
otherwise stated. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, 98%, Acros) and chloroform
( 99.9%, Acros) were distilled over 𝐶𝑎𝐻2 . All the lactides (L, DL) were recrystallized
using toluene and dried under high vacuum (-100 kPa). Macro initiators (PAMAM-G3BOC) used for ring opening polymerization (ROP) were freeze dried before use. All the
weighing for the ROP was done in a glove box.
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2.4.2 Synthesis
The copolymers were synthesized using a “dendrimer first” approach156 in which
the dendritic segment acts as an initiator for ROP of the linear segment (Fig. 6). Briefly,
the PAMAM dendron was synthesized by a divergent method in which the growth of the
dendron was originated from a core functional group. Using ethanolamine as the focal
point, a Michael addition with methyl acrylate formed a half-generation dendron, followed
by nucleophilic amidation with ethylenediamine to afford full generation dendrimers. This
was repeated up to generation 3 (G3). The amine-terminated dendron was treated with
di-tert-butyl dicarbonate in methanol to obtain HO-G3Boc in 90 % yield. The Janus-type
LDBC intermediates (i.e., precursors L-G3Boc and DL-G3Boc) were prepared by ROP of
L-lactide or D,L-lactide employing DBU as the catalyst. Variations in monomer feed gave
the precursors in weight percentages of 90, 70, 50, and 30 % with respect to polyester.
These percentages indicate the weight percentage of the hydrophobic block with respect
to the total weight of the amphiphilic block copolymer. For example, if the system is 90
%, the hydrophobic polyester block contains 90 % of the mass of the block copolymer.
Removal of the Boc protecting group using trifluoroacetic acid (TFA) afforded the final
LDBC products. Addi- tional information regarding molecular weight calculations and
nomenclature for the resulting copolymers as well as a detailed synthetic procedure are
presented in Appendix A.

2.4.2 Polymer Characterization
1

𝐻 NMR spectra of PAMAM dendrons and Boc-protected precursors were per-

formed on a Bruker Avance spectrometer (Bruker, Germany), operating at 500 MHz with
𝐶𝐷𝐶𝑙3 or 𝑀 𝑒𝑂𝐷 − 𝑑4 as the solvent and tetramethylsilane (TMS) as an internal standard. The degree of polymerization of PLA was estimated by the integration values of
the peaks corresponding to methylene protons as well as Boc protons using 1 𝐻 NMR.
Molecular weight and PDI of the copolymers were determined by gel permeation
chromatography (GPC). All the measurements were done using either DMF or THF.
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THF measurements were done at a flow rate of 1 mL/min at 35 𝑜 𝐶. A Shimadzu 20A
GPC system equipped with two Jordi Gel DVB500 columns and a differential refractive
index detector was used. Polystyrene standards (900–100,000 g/mol) were used for the
calibrations curve and the data were processed using a LCSolution ver.1.21 GPC option
software. DMF measurements were done at a flow rate of 0.3 mL/min at 50 𝑜 𝐶, on a
GPC system equipped with Waters Alliance HPLC System, 2695 Separation Module with
2 Tosoh TSKgel Super HM-M columns and Waters 2414 Differen- tial Refractometer (RI)
and Waters 2998 Photodiode Array Detec- tor (PDA) was used. Polystyrene standards
(900–100,000 g/mol) were used for the calibrations curve and data were processed using
the Empower 3 software (Waters). An addition of the electrolytic salt, LiBr (0.01%) was
done to minimize effects such as polymer aggregation and/or adsorption associated with
the polymer or the columns, enabling normal fractionation to occur.145,146,157
Matrix-assisted laser desorption time of flight mass spectrometry (MALDI-TOF
MS) data were acquired using a Bruker-Daltonics Autoflex III mass spectrometer with
delayed extraction using the reflector and positive ion mode. The samples were prepared
by combination of polymer analyte (2 mg/mL) in THF, trans-2-[3-(4-tert-butylphenyl)2-methyl-2-propenylidene] malononitrile (DCTB) (20 mg/mL) in THF as the matrix,
and sodium trifluoroacetate (2 mg/mL) in THF as the counter ion in a 15:15:1 ratio.
MALDI-TOF MS data were calibrated against SpheriCal dendritic calibrates from Polymer Factory (Stockholm, Sweden). 𝑀𝑛 and 𝑀𝑤 for all polymers were calculated using
the PolyTools software.
Thermal analysis of the LDBCs was conducted using thermogravimetric analysis
(TGA) and differential scanning calo- rimetry (DSC). TGA measurements were performed
on Seiko Instruments TG/DTA 6200 (platinum pan, room temperature to 600 𝑜 𝐶, ramp
rate of 20𝑜 𝐶𝑚𝑖𝑛−1 under a nitrogen atmosphere) and analyzed using the MUSE Analysis
software. DSC scans were performed on TA Instruments DSCQ1000-0620 v9.9 (sealed
aluminum pan, empty aluminum reference pan, ramp rate of 20𝑜 𝐶𝑚𝑖𝑛−1 , two heating
and cooling cycles) and analyzed using the Universal Analysis 2000 4.4A software.
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2.4.3 Nanoparticle Creation
The LDBCs having PLA:PAMAM weight ratios of 70:30, 50:50, and 30:70 were
formed into aggregates employing a direct dissolution method.158–160 Aggregates for LDBCs with ratios of 90:10 were formed using nanoprecipitation.16,159 For direct dissolution,
1 mg of LDBC was added to a vial of MilliQ water (1 mL) while stirring followed by sonication to achieve homogeneity. The nanoparticle suspensions were allowed to stabilize
at room temperature for 12 h. Nanoparticles formed via the nanoprecipitation method
used acetone or THF (according to the solubility properties of the each system) as the
organic solvent to dissolve 1 mg of LDBC in a glass vial. The solution was added dropwise
to a separate vial of MilliQ water (1 mL) while stirring and sonication followed thereafter. Acetone/THF was allowed to evaporate under a stream of nitrogen. Nanoparticles
solutions were allowed to equilibrate for 12 h before testing.

2.4.4 Nanoparticle Characterization
Aggregate size and zeta potentials (𝜁-potential) were determined by DLS. Measurements were carried out on a Malvern Instrument Zetasizer Nano ZS using a He–Ne
laser with a 633 nm wavelength, a detector angle of 173 at 25 𝑜 𝐶 using a He–Ne laser with
a 633 nm wavelength. The vesicle concentration was 1 𝑚𝑔𝑚𝐿−1 and size measurements
were performed three times on each sample to ensure consistency. The morphological
study of the aggregates formed from the LDBCs was carried out by TEM using a JEOL
1230 TEM. The TEM operated at 100 kV to collect images using a Gatan Orius 831
bottom mounted CCD camera. Samples were made up 1 day in advance, then filtered
and diluted within 1 hour of use. A second aliquot of sample B2 was set aside for 3 days
before filtering, diluting and preparing in the same manner. Formvar/carbon coated, 300
mesh grids were plasma cleaned just prior to applying 15 𝜇L of sample solution. The
sample was allowed to settle for 10 minutes before wicking away with a small wedge of
filter paper. Negative staining was carried out immediately followed by applying 7 𝜇L
of 1% uranyl formate to the grid and lightly wicking after 30 seconds. Prepared grids
air-dried for no less than 1 hour before TEM observation.
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For critical aggregation concentration (CAC) measurements, pyrene (1.7 mg, 8.41
𝜇mol) was dissolved in 3.34 mL of acetone and 40 𝜇L of the solution was added to 39.96
mL of deionized water. A series of 12 concentrations of the nanoparticle suspension
ranging from 10−8 𝑚𝑔𝐿−1 to 1000 𝑚𝑔𝐿−1 was prepared by serial dilutions, preparing
1.8 mL of each concentration. A 1.8 mL portion of the pyrene solution was added to
each vial, and these solutions were equilibrated for 48 h in the absence of direct light.
The fluorescence spectra were obtained on a Varian Cary fluorescence spectrometer from
Agilent Technologies. An emission wavelength of 390 nm was used for pyrene and the
excitation spectra were recorded from 300 to 360 nm. The ratio of emission intensities at
338 and 333 nm was graphed as a function of the log of the concentration. The CAC was
determined as the concentration at the intercept of the lines for the two linear regions of
the obtained graphs, as displayed in Figs. 52&53
Small angle X-ray scattering (SAXS) was performed at the Advanced Photon
Source at 9-ID-C beamline, operated by the X- ray Science Division at Argonne National
∘−

Laboratories. It covers a range in momentum transfer Q, from 0.002 to 0.5 𝐴 1, where
∘

𝑄 = 4𝜋 sin(Θ)/Λ, for the scattering angle � and X-ray wavelength Λ = 0.59𝐴 at energy
21 keV. All data reduction into intensity I(Q) or the macroscopic scattering cross section
𝑑Σ/𝑑Ω versus momentum transfer 𝑄 = |𝑄| was carried out following the standard procedures that are implemented in the Nika software package.161 The solvent was subtracted
as the background by measuring water separately.
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CHAPTER 3: POLYMERIZATION-INDUCED
SELF-ASSEMBLY WITH DENDRITIC MACRO
CHAIN-TRANSFER AGENTS

3.1 Introduction
Nanoparticles created from amphiphilic linear-dendritic block copolymers (LDBCs) have been hailed as promising candidates for a variety of applications, including
controlled release of drugs, bioimaging, catalysis, mineralization, and photochemistry.162
However, making these nanoparticles at an industrially relevant scale is still an open
challenge.3 The most commonly used method to create nanoparticles involves polymerization, characterization, purification, and reconstitution in a water-miscible non-selective
solvent (i.e., a solvent that dissolves both polymer blocks) before adding to water, usually
at very low concentrations (<1 wt%).163 The final step in this process is known as nanoprecipitation. The lack of scalability of these steps is compounded with the fact that a
priori prediction of nanoparticle size and morphology is diﬀicult with nanoprecipitation,
hindering its usage in biological applications.81
One promising nanoparticle formation method involves in-situ formation during
the reaction.164 This is referred to as polymerization-induced self-assembly (PISA). In
the case of aqueous PISA, this involves the chain extension of a hydrophilic polymer,
which is most commonly done using reversible addition-fragmentation-transfer polymerization (RAFT), in which the hydrophilic polymer acts as a macro chain-transfer agent
(mCTA).165 This chain extension is done with a monomer whose corresponding homopoly50

mer is lipophilic. Thus, the hydrophobic effect drives in-situ self-assembly into traditional nanoparticle morphologies (micelles, worms, vesicles, lamellae, etc.).166 With the
proper construction of phase diagrams, PISA formulations become highly reproducible,
alleviating a key issue with nanoprecipitation.167 In addition, these reactions can be performed at concentrations of up to 50% by weight, decreasing solvent and heating energy
requirements.168 As an important theoretical consideration, this also facilitates real-time
study of morphology as a function of lipophilic:hydrophilic mass ratio (LHR) with a much
greater degree of granularity. LDBCs have been shown not to obey the traditional mass
ratio heuristic169 used with linear diblock copolymers,98 and utilizing PISA to create
LDBCs could provide a more robust heuristic to predict nanoparticle morphology from
polymer structure.
PISA is commonly performed using either a dispersion or emulsion mechanism.
Dispersion is the most common, with a monomer that is soluble in the reaction solvent,
that polymerizes into a polymer that is insoluble in said solvent. This requires a significantly large Flory-Huggins (𝑋) parameter between the individual components, which
can be roughly defined as the strength of association between the individual polymer
components, in the case of a block copolymer.170 This has resulted in cases where a
small variation in monomer structure can be suﬀicient to drive phase separation.171 In
the case of emulsion, neither the polymer nor monomer are soluble in the reaction media,
and the reaction forms swollen micelles encapsulating monomer as the reaction proceeds.
Emulsion polymerization has a strong industrial precedent, being the primary method
of synthesizing latexes.172 The key differences between traditional latex synthesis and
emulsion PISA is that the surfactant participates in the polymerization rather than being removed during the purification step (often referred to as “sufactant-free” emulsion
polymerization173 ), and the controlled mechanism results in monodisperse particles as
opposed to the polydisperse particles created in latexes. This results in an acceleration
of reaction rate as the degree of polymerization increases, allowing many PISA reactions
to reach completion within a few hours.174
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Herein, to the authors’ knowledge, is the first successful example of PISA using a dendritic mCTA, summarized in Fig. 13. This mCTA is based on a derivative
of bis(2,2-hydroxymethyl propionic acid (bMPA), one of the few commercially available
dendrimers.175 The monomers used included benzyl methacrylate (BzMA) as a pilot system, followed by poly(2,2,2-trifluoroethyl methacrylate) (TFEMA) and 1-pyrenemethyl
methacrylate (PyMMA) statistical copolymers with the aim of creating a system for biological imaging.117 Given previous results, it is hypothesized that a dendritic mCTA will
affect the size and morphology of the nanoparticles formed relative to a linear analogue.176
The effects of concentration, ionic strength, co-solvents and pH were observed, revealing
several results that are surprising given previous work with PISA involving linear systems.

Figure 13: PISA of bMPA-pBzMA LDBCs

3.1.1 Design Rationale
This work seeks to lay the foundation for a reproducible, industrially relevant
protocol for the synthesis of vesicles for theranostic applications.18 Rather than using
traditional linear diblock copolymers, a dendron is used as one block due to a periphery
that can be functionalized with targeting ligands177–179 and superior drug encapsulation
52

eﬀiciency.180 Half a decade after the reported syntheses of PAMAM,64 Newkome,181 and
Frechet dendrimers,182 a polyester analog was successfully synthesized.183 This material
is easier to synthesize, and is more atom-economical than the path to make PAMAM,
using 1.5 monomer equivalents per reactive group rather than 5, and for certain synthetic
routes, less solvent is required, as the reaction is run at a 2M concentration rather than
<0.1M. Perhaps most importantly, previous work has explored bMPA as an alternative
to PAMAM for drug delivery, and found improvements in biocompatiblility and solution
stability.184 End-group modification ended up being necessary for these dendrons in order
to make them suﬀiciently water soluble. Building off of previous work,185 alanine endgroups were used, functionalizing the dendron periphery with free amine groups. This
allows bMPA to be used as a more direct analogue to PAMAM, with positively charged
amine groups facilitating endocytosis.15 However, this work found alanine-functionalized
bMPA to be less cytotoxic than polyamidoamine.
Traditionally, bMPA dendrons are made by Stieglich esterification, using
di(cyclohexyl)carboimide to create the monomer anhydride and N,N-dimethylaminopyridne as an activating agent.186 In 2014, Malkoch et al. developed an alternative to
create bMPA dendrons using N,N -carbonyldiimidazole (CDI) to activate the carbonyl
group and cesium fluoride (CsF) as a catalyst.187 Monomer activation only requires an
hour stirring at room temperature, rather than a separate reaction and column to form
the anhydride. In addition, Malkoch’s reaction does not require flame drying of glassware
or degassing. After carboxylate activation, alcohol and catalytic CsF are added, and the
reaction is stirred at 50𝑜 𝐶. It is then hypothesized that there is a 𝑐𝑎𝑡𝑖𝑜𝑛 − 𝜋 interaction
between the imidazole ring and the 𝐶𝑠+ ion, resulting in a weakened C-N bond. This
is coupled with 𝐹 − as a non-nucleophilic Lewis base, weakening the O-H bond of the
alcohol. The kinetics of this reaction are increased by the 2M concentration of imidazole
given off by the monomer activation, giving the solvent an effect analogous to an ionic
liquid.188 Though multiple dimethyl acetal deprotection conditions were attempted, the
most effective was determined to be a para-toluenyl sulfonic acid (p-TsOH) functionalized
polystyrene resin, Dowex 50WX80. The dendron is stirred with Dowex in methanol
53

(MeOH) for 3-48h, depending on dendron size, yielding the half-generation dendron.
The one downside of this approach is the additional time required to dry the dendron
under vacuum, as MeOH acts as a competitive nucleophile in the esterification reaction.
However, this yields the product selectively, and the purification is as simple as filtration
and drying in-vacuo.
Out of all of the monomers used for polymerization-induced self-assembly, benzyl methacrylate is by far the most researched.165 This is due to favorable reaction kinetics and a glass transition temperature (𝑇𝑔 ) that prevents assemblies from becoming
kinetically trapped.189 The possibility of 𝜋 − 𝜋 stacking between the benzyl groups also
facilitates a high 𝑁𝑎𝑔𝑔 and solution stability.190 This makes poly(benzyl methacrylate)
(pBzMA) ideal as a model system. This was done in parallel with poly(2,2,2-trifluoroethyl
methacrylate) (pTFEMA), which is of interest due to its ability to act as an MRI contrast
agent.118 In order to both enhance mechanical properties and insert a secondary imaging
motif, (1-pyrene)methyl methacrylate (PyMMA), was used as a complementary block.
Previous work191 utilized poly(methyl methacrylate-stat-PyMMA) with a 95:5 percent
feed ratio as a thermometer. This highlights the sensitivity of pyrene to the polarity of
its environment, which explains its ubiquity in CAC measurements.103 The aim in using
this as a statistical comonomer is as an inexpensive way to determine morphology as the
reaction proceeds. This work utilizes the same 95:5 molar ratio, with 2,2,2-trifluoroethyl
methacrylate rather than methyl acrylate, pTFEMA-stat-pPyMMA (pTsP). The general
reaction scheme, as well as structures for pBzMA and pTsP LDBCs are shown in Fig. 14.
It should be noted that emulsion PISA was done rather than dispersion due to
concerns regarding the relative hydrophobicity of bMPA relative to common monomers
used in dispersion PISA.171 Hydroxyl-terminated bMPA, even with 16 terminal hydroxyl
groups, is surprisingly insoluble in DI water. In addition to lacking solubility, this raises
concerns that the hydroxyl-terminated bMPA may not possess a suﬀiciently high 𝑋
parameter to self-assemble when used with monomers commonly applied to dispersion
polymerization, such as 2-hydroxypropyl methacrylate or 2-methoxyethyl acrylate.165
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Figure 14: a. Structure of mCTA and general polymerization scheme b. LDBCs targeted in this study. Note:
trifluoroacetate counterions of groups omitted for clarity

3.1.2 Empirical Considerations and Characterization of PISA
Many non-intuitive results have emerged from PISA studies. For example, adding
water to an alcoholic dispersion polymerization of pBzMA has been shown to accelerate
reaction kinetics, but limit the morphologies formed to spheres.80 Highly abnormal morphologies, such as “framboidal” vesicles76 and jellyfish77 have also been observed. The
observed morphologies as a function of degree of polymerization (DP) is a function of
both concentration and solvent choice, represented in Fig. 15.192 For examples, PAApBzMA nanoparticles have been shown to be locked in micellular morphologies at an
overall reactant weight ratio of 10% relative to solvent, but if the concentration is increased, a larger variety of morphologies are observed.171 This can be hypothesized as
resulting from PISA operating on two different timescales: that of reactivity and that of
self-assembly. This result suggests that self-assembly is more sensitive to concentration
effects than RAFT.193 However, once a phase diagram is constructed for a given system,
it allows the desired morphology to be selectively targeted.
PISA follows a convoluted kinetics pathway (Fig. 15), owing to the reaction
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Figure 15: Illustration of PISA. Adapted with permission from Bauri et al. Copyright 2009 RSC

happening in several time domains. Previous work194 has determined that for an emulsion
PISA, there is a nucleation phase, often lasting several hours, at the onset of the reaction.
After this nucleation phase, monomer-swollen micelles were shown to develop, resulting
in an increase in reaction rate. Due to the LHR of the mCTA, it was hypothesized that
it may self-assemble on its own, effectively “seeding” the polymerization.195
Several methods are commonly utilized to characterize PISA formulations. The
most basic and important measurement in determining polymer kinetics is 1 𝐻 NMR.
Monomer conversion can be measured as the ratio of monomer concentration at time t
versus at the start of the reaction, or 𝑙𝑛([𝑀 ]𝑡 /[𝑀 ]0 ). If a reference peak exists, DP can be
directly measured from integration of the main chain polymer peaks. In addition to this,
it is desirable to measure GPC or MALDI simultaneously, as PDI is the most important
factor in measuring whether a polymerization is truly living. If this is the case, PDI will
only increase negligibly as a function of DP, whereas PDI will increase linearly as the
reaction progresses for a traditional radical polymerization.
Nanoparticle morphology is most often monitored by dynamic light scattering
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(DLS) and transmission electron microscopy (TEM). DLS allows for aggregate measurement of size and polydispersity in solution, and TEM allows for precise determination
of morphology. Depending on the choice of monomer, UV-vis spectroscopy, fluorometry, or

19

𝐹 NMR can be used to monitor polymerization kinetics.196 One of the aims

of using PyMMA as a monomer is for in-situ monitoring of nanoparticle formation by
monitoring the formation of excimers that form when the pyrene units are incorporated
into gradually more hydrophobic environments within the polymer nanoparticle.191

3.2 Results and Discussion
The mCTA was synthesized divergently, using Malkoch’s method to synthesize
an azide-cored bMPA dendron, followed by copper-cataylzed alkyne-azide cycloaddition
(CuAAC) between the dendron and chain-transfer agent as outlined in Fig. 25. The
tert-butyl carbonate (Boc) groups were then removed with trifluoroacetic acid (TFA),
resulting in the trifluoroacetate salt of the cationic dendron. The mCTA was incubated
for 1h in a cool, dark place after dissolving in water with sonication. TEM of the mCTA
showed self-assembly (Fig. 79), but revealed a large variety of morphologies with a
high PDI, suggesting low stability of the resulting nanostructures. Addition of monomer
resulted in phase separation, but upon degassing the solution turned turbid, suggesting
that the mCTA acts as an emulsion stabilizer. Given the pH sensitivity of the initiator,
2,2’-azobis(2-methylpropionamidine)dihydrochloride (V50), it is important to note that
the pH of the mCTA in water at a concentration of 0.37 M is 1.7. In addition, alaninefunctionalized bMPA has been shown to be relatively unstable at neutral/basic pH at
elevated temperatures.185 The mCTA/initiator ratio was altered from 10:1 to 3:1 in the
preliminary stages of this study, but it was ultimately decided to hold this factor constant,
as increasing the amount of initiator introduces the risk of this polymerization losing its
living nature.197 The mCTA:V50 ratio was fixed at 5:1 for this work, due to a strong
literature precedent of this ratio producing well-controlled PISA.165
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PISA of pBzMA
Initial reactions targeted a 67:33 LHR at 100% conversion. The reaction was attempted at different concentrations, measured as the weight percentage of mCTA and
monomer relative to water (wt%). Mimicking previous work,78 10, 20, and 30 wt% were
chosen. Interestingly, no polymerization was observed in the case of the 10% condition.
The 20 and 30 wt% reactions exhibited little difference in kinetics, but the 30 wt% reaction formed larger and more polydisperse aggregates, along with significant floccuation.
20 wt% was chosen for subsequent studies. The reaction had an incubation period of
approximately 40 min (Fig. 17), suggesting that this is not a seeded polymerization, but
a traditional emulsion PISA. This reaction reached full conversion within 90 min, with
a DP of 26 by 1 𝐻 NMR (Appendix B, Fig. 74) compared to a theoretical DP of 20.7.
pBzMA reactions turned a milky white upon reaction progression, similar to previous results with similar systems.189 The evolution of polymer conversion was monitored by 1 𝐻
NMR, and the morphologies formed were monitored using DLS and TEM using uranyl
acetate as a negative stain.

Figure 16: TEM of pBzMA PISA at a-c. 4107 Da and d-f. 7099 Da

Figure 16 shows the evolution of this polymerization from well-defined spherical
aggregates which are believed to be micelles (a-c) to micelle fusion (e), worm formation
(Fig. 13), and finally pinching off into vesicles (Fig. 16f). Worms ranged in length from
257 to 746 nm, and from 23 to 41 nm in width. Given the relatively low stability of
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worms,78 very few were observed, with the predominant morphology still being spherical
aggregates. The segmented worm present in Fig. 16e appears to consist of vesicles that
are abnormally large for this molecular weight,198 ranging from 309 to 381 nm in diameter.
With linear block copolymers, this LHR would be expected to form exclusively vesicles.
In order to achieve vesicles at this LHR, the reaction was attempted a second time using
a higher monomer feed.

Figure 17: a. Kinetics of pBzMA polymerization at different LHRs. Dashed lines represent the theoretical
DP for each reaction. b. DLS taken of 83:17 pBzMA over the course of the reaction

Fig. 17 exhibits a loss of molecular weight control when the feed ratio is increased.
The precise reason for this requires additional investigation, but the resulting monodisperse LDBCs with an 83:17 LHR proved to form well-defined, monodisperse spherical
aggregates averaging 100 nm in diameter, believed to be vesicles, shown in Fig. 18. To
the authors’ knowledge, this is the first reported example of vesicles being formed from
emulsion PISA with a cationic mCTA.199

Figure 18: TEM of pBzMA PISA at 20,299 Da

Changes in morphologies also appear to result in changes in polymerization kinet59

ics, as described in previous works.164 After very slow living polymerization for the first
50 min, the reaction rate increases drastically between 50 and 60 min (Fig. 17, Appendix
B, Fig. 72), corresponding to the onset of micelle nucleation. This was confirmed by DLS,
with insuﬀicient signal obtained at 50 min, as opposed to monodisperse 28.2 nm micelles
formed at the 60 min mark (Fig. 17). Between 70 and 80 min, the rate decreases, with
micelle size and DP staying constant until between 90 and 120 min, where the reaction
rate again increases, likely due to micelles fusing into worms, which is further confirmed
by Fig. 16. An important discrepancy is that fusion of micelles into worms happens at a
higher DP for the 83:17 LHR reaction. This indicates a slower rate of unimer exchange
between micelles, which can be attributed to the reaction rate being significantly faster
than the exchange rate.200

PISA of pTFEMA and pTsP
PTFEMA LDBCs were synthesized using a 67:33 LHR. Unlike pBzMA, this did
not reach full conversion by NMR, only having a DP of 13.5 after 12h stirring (Appendix
B, Fig. 76). GPC of this system proved diﬀicult due to the low dRI of pTFEMA, an
issue commonly reported for these systems.196 pTFEMA reactions remained a nearly
transparent yellow throughout the reaction due to this reason. Interestingly, Fig. 19
shows a stronger aggregation between the resulting spherical aggregates versus pBzMA
LDBCs. This could be hypothesized as being due to a difference in interfacial tension
caused by the difference in hydrophobicity between the two polymers.201
DLS attempted at the same 1000-fold dilution as pBzMA polymers resulted in
a statistically insignificant count rate. Both to determine the proper concentration for
analysis, and to evaluate the viability of these systems as theranostics, critical aggregation
concentration (CAC) data was obtained for both pTFEMA and pBzMA LDBCs (Fig. 78).
It was observed that the CAC of pBzMA was 27.5 mg/L which is comparable to several
drug delivery systems in clinical trials.36 However, pTFEMA had a CAC of 239 mg/L,
which is far too high for pharmaceutical applications, in addition to explaining the lack
of DLS signal. PyMMA was added both to lower the CAC by the introduction of 𝜋 − 𝜋
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Figure 19: TEM of pTFEMA PISA at full conversion (6019 Da). Inset corresponds to 25000x magification

stacking, as well as providing a fluorophore which responds to morphology changes.

Figure 20: a. Kinetics of pTsP polymerization at different timepoints (pTFEMA DP). b. DLS taken over the
course of the reaction

Poly(TFEMA-stat-PyMMA) with a 95:5 feed ratio of TFEMA:PyMMA (pTsA)
was synthesized with a target LHR of 67:33. Within 2h, the reaction appeared to reach
full conversion, with a DP of 23 for TFEMA and 1.5 for PyMMA (Appendix B, Fig.
77) The kinetics of these systems differ drastically relative to pBzMA systems (Fig. 20).
There was a faster period of nucleation with these systems, with oligomer formation
occuring as early as 15 min. The reaction kinetics are almost perfectly linear until nearly
all of TFEMA is consumed. 𝑀𝑛 was calculated exclusively from TFEMA monomer
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conversion, as the low equivalency of PyMMA made accurate characterization by 1 𝐻
NMR diﬀicult. This system exhibits the same level of molecular weight control as 67:33
LHR pBzMA, overshooting the theorectical by a factor of 1.5. However, the change
in morphology as the reaction progresses bears no similarity to pBzMA systems. The
resulting DLS is effectively bimodal, with trace indications of micron-sized aggregates.
As the reaction progresses, the large aggregates averaging 164 nm decrease, resulting in a
relatively monodisperse population of 21-24 nm spherical aggregates. Fig. 21 gives some
indication as to why this is the case.

Figure 21: TEM of pTsP PISA after a-c. 60 min d-f. 120 min

A different assembly mechanism appears to be present for these systems, involving
fission of large spherical objects into smaller ones. At 60 min (Fig. 21a-c), TEM shows
mostly spherical particles ranging from 98 to 648 nm in diameter, along with several small
spherical particles ranging from 11 to 19 nm, plus one giant sphere with a diameter of
1.9 𝜇m. It is unlikely that the larger spheres are vesicles, due to both the relatively low
contrast of these images, in addition to the low LHR early in the reaction. At 120 min
(Fig. 21d-f), 99-109 nm spheres are shown pinching off into 8-19 nm spheres. The larger
observed size in DLS is likely due to scattering of fused structures, rather than individual
micelles, such as the 524 nm long cluster of spheres observed in the 21f. It is important
to note that the difference in DP between the Fig. 21a-c and the Fig. 21d-f is only ~4,
impling that this size change is unlikely to be a result of a change in LHR, and rather is
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thermally-induced.202

Figure 22: PyMMA fluorescence as a function of reaction progression

Self-assembly was indirectly monitored using fluorometry (Fig. 22). Self-assembly
was confirmed by the disappearance of the peak corresponding to free pyrene fluorescence
at 395 nm, as well as the appearance of an excimer peak at approximately 475 nm.103 At
90 min, the monomer fluorescence appears to increase, accompanied by blue shifting of the
excimer. This is hypothesized to be due to unimer exchange occuring during this period,
exposing unreacted PyMMA to the surrounding water. Interestingly, after 1 h incubation
at 60 𝑜 𝐶 after >99% conversion, the pyrene excimer shifts to 498 nm. Similar observations
were observed when 2,2,2-trifluoroethanol was added to solutions of pyrene functionalized
helical proteins with the aim of disrupting intermoleculer interactions.203 This implies
that the average distance between PyMMA monomers decreased, likely corresponding
to a morphological change. This also furthers the hypothesis that self-assembly of these
systems is primarily thermally induced rather than polymerization induced.

Effect of Ionic Strength and Chain Mobility
A well known issue with aqueous PISA is kinetic trapping in micelle morphologies. Several factors have been discovered which contribute to this phenomenon.204
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First, the length of the solvophilic chain has been shown to affect the access to complex morphologies.80 Specifically, a long solvophilic chain has been shown to limit morphologies formed to small spheres.205 The compact nature of dendrons relative to linear
analogues theoretically makes dendrons an ideal fit as a stabilizer block, especially if large
nanostructures such as giant vesicles206 are desired. Concentration has also been known
to affect the resulting morphologies, with higher concentrations favoring higher-order
morphologies.207 This is until either flocculation occurs or the reaction mixture becomes
too viscous to facilitate polymerization. Polymer chain mobility also dictates whether a
polymer will become kinetically trapped. This is due to a rigid chain not being able to rearrange at a low enough timescale to extend spheres into worms. This has been addressed
in several ways, including incorporating solovophilic co-monomers into the solvophobic
chain204 and adding a co-solvent which can solvate some of the solvophobic chain.208 Ionic
strength of the solution is an additional factor affecting PISA, especially with an ionic
mCTA.209 This is hypothesized to be due to suppression of charge repulsion between
the ionic groups of the mCTA, decreasing the radius of curvature of the nanoparticle,
facilitating a change in morphology.74
CTA terminus polarity, mCTA/initiator ratio194 , and pH209 have been shown to
affect kinetic trapping. However, these were held approximately constant for this study,
as bMPA is relatively unstable at neutral/basic pH.210 The mCTA/initiator ratio was
adjusted in the early stages of this study, but it was ultimately decided to hold this factor
constant, as increasing the amount of initiator introduces the risk of this polymerization
losing its living nature. Finally, the CTA terminus polarity is effectively the end-groups
of the dendron, which is outside the scope of this study.
Growing pBzMA in aq. NaCl resulted in spheres averaging 32.5 nm by TEM,
and 41.8 nm spheres when dioxane was used as a co-solvent (Fig. 23). This result is
counter-intuitive as appears to limit the morphology formed to exclusively small spherical
aggregates. This runs contrary to previous results with linear systems.209 One possible
explanation for this is the pockets within the mCTA possessing ester groups capable of
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Figure 23: TEM of pBzMA PISA in a-c. 0.6M NaCl(aq) d-f. 0.6M NaCl in 4:1 water:dioxane, both at full
conversion (15,000 Da)

complexing with sodium ions.211 This, combined with 0.6M NaCl likely being a superior
solvent for the mCTA, could have had the effect of increasing the radius of curvature so
that more dendron surface area could interact with the solvent. In addiiton, having a
more ionic solution limits exchange kinetics of unimers, as pBzMA would seek to avoid
the ionic media. Proving this hypothesis could potentially be done by a mixture of
modeling212 and testing of electrolytes with larger ionic radii, which is beyond the scope
of this work.

Figure 24: a. Kinetics of pBzMA at different timepoints. b. Morphologies formed at full conversion (15,000
Da) Effect of salt and co-solvent on reaction kinetics

Spherical particles formed in 4:1 water:dioxane were 20.1 nm larger than those
formed in 0.6M NaCl(aq) (Fig. 23, Table 6), but there was also a larger aggregate in the
purely aqueous reaction that was not seen in its TEM. There was a pronounced difference
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in kinetics, outlined in Fig. 24. Both salt and a salt/dioxane mixture seemed to exhibit
previous issues with molecular weight control, consistently leading to polymers with an
𝑀𝑛 1.5x that of the theoretical weight. It was observed that using dioxane as a co-solvent
increased the rate of kinetics, but also increased the nucleation time.
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3.3 Conclusions and Future Work
This work presents the first reported attempt to conduct PISA using a dendritic
mCTA. This has the potential to facilitate easier and more reproducible access to desired
nanoparticle morphologies using industrially relevant conditions. This also represents the
first successful emulsion PISA with a cationic mCTA, which opens up the design space
for PISA systems to a wider variety of mCTAs, in addition to increasing the potential
of PISA systems for drug delivery.15 Modification of reaction conditions revealed several
results that exemplify the effect of polymer topology on PISA, including the creation
of vesicles despite a cationic solvophilic block and high ionic strength solutions limiting
morphologies observed to micelles. Introduction of a fluorophore into the hydrophobic
chain also proved to be an indirect method to gauge self-assembly, as shifts in excimer
fluorescence were observed as the morphology chagned.
The most important follow-up studies for this project include testing the effect
of more hydrophilic comonomers (e.g. 2-hydroxypropyl methacrylate) to increase chain
flexibility and testing alternative end-groups for the mCTA, specifically with different
charges. For biomedical applications, it is desireable to explore less toxic monomers,
introduce a more biologically relevant dye than pyrene,213 and explore the 𝑇2 relaxation
times of pTFEMA copolymers to evaluate their merit as MRI contrast agents.122 It is also
fundamental to develop a full phase diagram of these systems. Nonetheless, this paper
provides empirical evidence of monodisperse nanoparticle formation of these materials,
making them ideal for both application-driven research as well as fundamental studies of
LDBC self-assembly.

3.4 Experimental
3.4.1 Materials and Methods
All chemicals were purchased from commercial sources and used without further
purification unless indicated otherwise. The purity of N,N-carbonyldiimidazole (CDI)
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pTFEMA
pTsP

None
Salt†
Salt† +
Dioxane‡
None
None

None

pBzMA

pBzMA
pBzMA
pBzMA

Additive

Polymer

N/A
70

80
80
120

90

Rxn. time
(min)

5347
5347

10808
10707
10707

5460

Theo. 𝑀𝑛
(Da)

6019
6133

20299
15019
15019

6395

s, v
s

v
s
s

s, v

147.2, 1535

48.8
68.92

19.57, 164.7

𝑀𝑛 (NMR, Morphologies Diameter
Da)
Observed
(DLS, nm)

0.113,
0.259*

0.147
0.186

0.113,
0.058*

PDI

Table 6: Aggregate results of PISA iterations. Rxn time is defined as the time neceary to reach >90% completion by NMR. Morphologies: s=sphere, v=vesicle *Obtained
from distribution fit rather than cumulant. † 0.6M solution of NaCl ‡ 20% by volume co-solvent. in water.

was determined by NMR before usage, and it was recrystallized with acetonitrile if it
was found to be <90%. Amberlyst-A21 resin was previously cleaned by suspending in
three separate batches of MeOH (approximately equal to resin volume) for 2h. Dowex
50WX8 resin was purified by vacuum filtering and washing with alternating volumes of
methanol and tetrahydrofuran until no color was observed in the filtrate (approximately
3 equivalent volumes of solvent). BzMA and TFEMA were percolated through a small
∘

column of basic alumina prior to usage. These were stored at -10 𝑜 𝐶 over 4𝐴 molecular
sieves. PyMMA was dissolved in acetone, passed over a small column of basic alumina,
and dried under vacuum overnight, then stored at -10 𝑜 𝐶 Before analysis by DLS, TEM,
and/or fluorometry, the reaction aliquots were diluted in deionized water with sonication
to a concentration of 0.2 mg/mL for pBzMA LDBCs, and 0.6 mg/mL for pTFEMA
LDBCs.

3.4.2 Instrumentation
NMR 1 𝐻 and

13

𝐶 spectra were recorded in deuterated solvents on a Bruker

AVANCE 500 NMR Spectrometer. J values are expressed in Hz and quoted chemical
shifts are in ppm downfield from tetramethylsilane (TMS) reference using the residual
protonated solvents as an internal standard. The signals have been designated as follows:
s (singlet), d (doublet), t (triplet), m (multiplet). Analysis was done using MestreNova
14.0.
GPC GPC measurements were done at a flow rate of 0.3 mL/min at 50 𝑜 𝐶, on a
GPC system equipped with Waters Alliance HPLC System, 2695 Separation Module with
2 Tosoh TSKgel Super HM-M columns and Waters 2414 Differential Refractometer (RI)
and Waters 2998 Photodiode Array Detector (PDA) was used. Polystyrene standards
(900–100,000 g/mol) were used for the calibrations curve and data were processed using
the Empower 3 software (Waters). An addition of the electrolytic salt, LiBr (0.01%) was
done to minimize effects such as polymer aggregation and/or adsorption associated with
the polymer or the columns, enabling normal fractionation to occur.145,146,157
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DLS Aggregate size and zeta potential (𝜁-potential) were determined by a Malvern
Instruments Zetasizer Nano ZS using a He–Ne laser with a 633 nm wavelength, a detector
angle of 173 at 25 𝑜 𝐶 using a He–Ne laser with a 633 nm wavelength. Measurements
were done in triplicate to ensure reproducibility.
TEM A JEOL 1230 TEM was operated at 100 kV using a Gatan Orius 831 bottom
mounted CCD camera. TEM samples were prepared by adding 10 𝜇L diluted nanoparticle
solution to a 300 mesh Formvar/Cu grid. Water was wicked away with cellulose weighing
paper, and the slide was then incubated on a drop of 1% uranyl acetate stain for 20
sec. Excess water was again wicked away, and the grids were dried at room temperature
in a vacuum oven for 45 min before analysis. Image analysis was done using Fiji 2.1.2
and a custom Python 3.7 script.214
Fluorometery Fluorescence measurements were taken on a Perkin-Elmer MFP44 fluorometer at room temperature, using Hellma fluorescence cuvettes with a 10x10
mm pathlength and a 3.5 mL volume. Analysis was done using FluorEssence 3.5 software
(Horiba).

3.4.3 Synthesis
General Esterification Procedure
BMPA dendron growth was adapted from previously reported procedures.215
bMPA (1.5eq per hydroxyl group) was suspended in a solution of EtOAc (2.2 M), and
N,N-carbonyldiimidazole (CDI, 1.65eq per hydroxyl group) was carefully added. After
1h stirring at rt and confirmation of completion via NMR, CsF (0.24eq per hydroxyl
group of dendron) was added, followed by the alcohol initiator. The solution was heated
at 50𝑜 𝐶 overnight, or until completion was observed via 1 𝐻 NMR. After cooling to room
temperature, the crude was stirred overnight with water added at a 5:1 volume ratio to
EtOAc. A tenfold volume excess of EtOAc was added relative to reaction volume and
washed with 0.25M amount of the following solutions: 3x 1M 𝑁 𝑎𝐻𝑆𝑂4 , 3x saturated
𝑁 𝑎𝐻𝐶𝑂3 , and 1x brine. The organic layer was dried with magnesium sulfate and
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concentrated in vacuo.

General Deprotection Procedure
The acetal-protected dendron was dissolved to a concentration of 6.7wt% in MeOH.
Dowex resin was added at a 350% weight ratio relative to dendron. After the disappearance of the doublet at 1.4 ppm via 1 𝐻 NMR, the resin was removed via vacuum filtration,
and MeOH was removed in vacuo. Any residual water was removed via air-drying. If any
impurities remained via 1 𝐻 NMR, the hydroxyl-terminated dendron was recrystallized
from EtOAc or stirred with petroleum ether and charcoal and filtered over Celite.

General Polymerization Procedure
The mCTA and solvent(s) were added to a gas-tight conical vial and sonicated,
and then incubated 1h in a dark place. Initiator and monomer(s) were then added, and
the solution was purged with Ar for 30 min. The vial was then placed in a 60𝑜 𝐶 bath
and monitored by NMR.

Figure 25: Synthesis of mCTA
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APPENDIX A: SUPPLEMENTARY INFORMATION FOR
CHAPTER 2

Additional Materials and Methods Details
Chemical shifts (𝛿) are given in parts per million (ppm) relative to TMS and referenced to
residual protonated solvent purchased from Cambridge Isotope Laboratories, Inc. (𝐶𝐷𝐶𝑙3 : 𝛿H 7.26
ppm, 𝛿C 77.16 ppm; DMSO-d6: 𝛿H 2.50 ppm, 𝛿C 39.52 ppm, MeOD: 𝛿H 3.31, 4.87 ppm). Abbreviations
used are s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), hp (heptet), b (broad), and m
(multiplet).

Synthetic Details
General Half-Generation (Gn.5) Procedure To a stirred solution of methyl acrylate (MA)
in methanol (MeOH)(50% w/w) at 0𝑜 𝐶, Gn.0 dendron (10g) in 50mL MeOH was added dropwise. After
addition, this was allowed to warm to room temperature (rt), then stirred until completion by 1 𝐻 NMR.
Upon completion, MA was co-evaporated in-vacuo 3x with butanol, 3x with reagent alcohol, and 3x with
MeOH. This was followed by an additional NMR to ensure completion.
General Full-Generation (Gn.0) Procedure To a stirred solution of ethylene diamine (EDA,
2𝑛 𝑥10𝑒𝑞) in MeOH (50% w/w) at 0𝑜 𝐶, Gn.5 dendron (10g) in 50mL MeOH was added dropwise. After
addition, this was allowed to room to room temperature (rt), then stirred until completion by 1 𝐻 NMR.
Upon completion, MA was co-evaporated in-vacuo 3x with butanol, 3x with reagent alcohol, and 3x with
MeOH. This was followed by an additional NMR to ensure completion. {figure PAMAM-G-0.5 (2) To
the stirred solution of ethanolamine (10.0 g, 0.16 mmol) in 50 mL of methano lunder salted ice, methyl
acrylate (MA) (70.75 g, 0.82 mmol) in 150 mL of methanol was added dropwise. After the completion
of addition, the reaction mixture was allowed to come to room temperature and then was subjected to
heating at 35𝑜 𝐶 overnight. Upon 1 𝐻 NMR confirmation of completion, MA was co-evaporated in-vacuo
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three times with butanol, three with reagent alcohol, and three with MeOH until complete removal was
confirmed by 1 𝐻 NMR in 𝐶𝐷𝐶𝑙3 .

1

𝐻 NMR (𝐶𝐷𝐶𝑙3 , 500 MHz) 𝛿 2.46- 2.51(2H, t), 2.59-2.63 (2H,

t), 2.79-2.84 (4H, t), 3.56 – 3.60 (2H, t), 3.68(6H, s); Solvent impurity: MeOH
PAMAM-G-1.0 (3) To the stirred solution of ethylenediamine (EDA) (52.1 g, 0.866 mmol)
in 100 mL of methanol under salted ice, PAMAM-G0.5 (10.17g, 0.043mmol) in 50 mL of methanol was
added dropwise. After the completion of addition, the reaction mixture was allowed to come to room
temperature and then was subjected to heating at 35𝑜 𝐶 for overnight. Upon 1 𝐻 NMR confirmation of
completion, MA was co-evaporated in-vacuo three times each with butanol, reagent alcohol, and MeOH
until complete removal was confirmed by 1 𝐻 NMR in MeOD. 1 𝐻 NMR (MeOD, 500 MHz) 𝛿 2.34-2.38
(4H, t), 2.63 (2H, t), 2.68-2.72 (4H, t), 2.78-2.83(4H, t), 3.21-3.25 (4H, t), 3.45 (2H, s), 4.87. Solvent
Impurities: n-BuOH 𝛿 0.90-0.95(3H, t), 1.31-1.40 (2H, m), 1.43-1.54 (2H, m).
PAMAM-G-1.5 (4) To the stirred solution of MA (106.60 g, 1.24 mmol) in 200 mL of methanol
under salted ice, PAMAM-G1.0 (11.96 g, 0.124 mmol) in 50 mL in methanol was added dropwise. After
the completion of addition, the reaction mixture was allowed to come to room temperature and then
was subjected to heating at 35𝑜 𝐶 for two days. Upon 1 𝐻 NMR confirmation of completion, MA was
co-evaporated in-vacuo three times with butanol, three with reagent alcohol, and three with MeOH until
complete removal was confirmed by 1 𝐻 NMR in 𝐶𝐷𝐶𝑙3 .

1

𝐻 NMR (𝐶𝐷𝐶𝑙3 , 500 MHz) 𝛿 2.38-2.40

(4H, t), 2.42-2.46 (8H, t), 2.53-2.57 (4H, t), 2.64-2.65 (2H, t), 2.73- 2.78 (8H, t), 2.81- 2.85 (4H, t),
3.27-3.29 (4H, t), 3.61, 3.63 (2H, t), 3.67 (12H, s); Solvent Impurities: MeOH
PAMAM-G-2.0 (5) To the stirred solution of EDA (47.56 g, 792.59 mmol) in 100 mL of
methanol under salted ice, PAMAM-G1.5 (12.51g, 19.73 mmol) in 60 mL in methanol was added dropwise.
After the completion of addition, the reaction mixture was allowed to come to room temperature and
then it was subjected to heating at 35𝑜 𝐶 for three days. Upon 1 𝐻 NMR confirmation of completion,
MA was co-evaporated in-vacuo three times with butanol, three with reagent alcohol, and three with
MeOH until complete removal was confirmed by 1 𝐻 NMR in MeOD. 1 𝐻 NMR (MeOD, 500 MHz) 𝛿
2.39-2.44 (12H, t), 2.60-2.65 (4H, t), 2.67-2.69 (2H, t), 2.75- 2.79 (8H, t), 2.81-2.85 (12H, t), 3.28-3.32
(12H, t), 3.35-3.36 (2H, t), 3.65-3.69 (2H, t); Solvent Impurities: MeOH, t-BuOH
PAMAM-G-2.5 (6) To the stirred solution of MA (71.84 g, 834.48 mmol) in 150 mL of
methanol salted ice, PAMAM-G2.0 (12.45 g, 16.689 mmol) in 60 mL in methanol was added dropwise
under. After the completion of addition, the reaction mixture was allowed to come to room temperature
and then it was subjected to heating at 35𝑜 𝐶 for four days. Upon 1 𝐻 NMR confirmation of completion,
MA was co-evaporated in-vacuo three times with butanol, three with reagent alcohol, and three with
MeOH until complete removal was confirmed by 1 𝐻 NMR in 𝐶𝐷𝐶𝑙3 . 1H NMR (𝐶𝐷𝐶𝑙3 , 500 MHz) 𝛿
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2.35-2.38 (12H, t), 2.42-2.45 (16H, t), 2.53-2.56 (8H, t), 2.57-2.59 (4H, t), 2.60 (2H, t), 2.74-2.81 (28H,
m), 3.26-3.29 (12H, t), 3.62-3.62 (2H, t), 3.67 (24H, s). Solvent Impurities: IPA; MeOH
PAMAM-G-3.0 (7) To the stirred solution of EDA (34.31 g, 571.0 mmol) in 70 mL of methanol
under salted ice, PAMAM-G2.5 (10.24 g, 7.137 mmol) in 50 mL in methanol was added dropwise. After
the completion of addition, the reaction mixture was allowed to come to room temperature and then it
was subjected to heating at 35𝑜 𝐶 for four days. Upon 1 𝐻 NMR confirmation of completion, MA was
co-evaporated in-vacuo three times with butanol, three with reagent alcohol, and three with MeOH until
complete removal was confirmed by 1 𝐻 NMR in MeOD. 1H NMR (MeOD, 500 MHz) 𝛿 2.38-2.42 (28H,
t), 2.59-2.61 (12H, t), 2.73-2.77 (16H, t), 2.81-2.84 (28H, t), 3.26-3.30 (28H, t), 3.64-3.67 (2H, t). Solvent
Impurities: n-BuOH, MeOH and t-BuOH
PAMAM-G-3-BOC (8) To the stirred solution of PAMAM-G3.0 (15.06 g, 9.041 mmol) in 150
mL of methanol under salted ice, di-tert-butyl dicarbonate (Boc Anhydride) (39.85 g, 0.182 mmol) in
120 mL in methanol was added dropwise. After complete addition of Boc Anhydride, the reaction was
allowed to warm to room temperature. The reaction continued at room temperature for two days. Upon
1

𝐻 NMR confirmation of completion, a single rotovap ensued. The PAMAM product was dissolved into

a minimal amount of DCM which was followed by a precipitation via separatory funnel into 5x mL of
stirring, pure hexane. After settling of the precipitate, the hexane layer was decanted, and the remaining
product was air-dried. This precipitation, decanting, and air-drying process was repeated twice more. A
final 1 𝐻 NMR ensured the removal of Boc Anhydride.

1

𝐻 NMR (𝐶𝐷𝐶𝑙3 , 500 MHz) 𝛿 1.44 (72H, s),

2.37 (28H, t), 2.55 (14H, t), 2.75 (28H, t), 3.26 (28H, t), 3.34 (20H, t), 3.64 (2H, t); Solvent Impurities:
DCM
(90/70/50/30) – (DL/L) – G3 – BOC (9) To a stirred solution of PAMAM – G3 – BOC
(5) (1 g, 0.4 mmol) and L or DL – lactide (1.5 g, 11 mmol) in chloroform (12.5 ml), DBU (76 µL, 1 mmol)
was added under inert atmosphere and then stirred for 4 h. Benzoic acid (186 mg, 1.5 mmol) was added
to the reaction mixture which was then stirred for another 30 minutes. The final reaction mixture was
added dropwise to 250 ml of a solvent mixture: containing diethylether:hexane:MeOH (15:5:1) and stirred
for 30 min. Stirring was stopped and the reaction mixture was allowed to settle down. The resulting
white precipitate was filtered out, dissolved in chloroform (5 ml), and the precipitation procedure was
repeated three times to get pure product. The resulting white powder was dried under high vacuum at
45 𝑜 𝐶 for 24 hours to obtain the pure product with 91% yield (2.3 g). 1H NMR (𝐶𝐷𝐶𝑙3 , 500 MHz) 𝛿
1.42 (72H, s), 1.56 (174H, m), 2.36 (28H, b), 2.53 (14H, b), 2.73 (28H, b), 3.23 (28, b), 3.32 (18, b), 3.46
(2, t), 5.18 (58, m).
(All amounts and NMR chemical shifts are given for the 70-(DL/L)-G3-BOC. For the 90, 50 and 30
systems, procedure is the same but amounts of the materials are varied according the weight ratio
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calculations. Analysed NMR spectra for all the systems are given in the NMR spectra section)
(90/70/50/30) – (DL/L) – G3 – 𝑁𝐻3+ 𝑇 𝐹 𝐴− (10) To a stirred solution of (6) (1g, 0.16
mmol) in chloroform (15 mL), trifluoroacetic acid (TFA) (1.5 mL,10% v/v) was added and stirred for 30
minutes. The final reaction mixture was air dried to remove the TFA, dissolved in 5mL of chloroform and
added dropwise to 250 ml of diethyl ether. After stirring for 30 min, the reaction mixture was allowed
to settle down. The resulting white precipitate was filtered out, dissolved in chloroform (5 ml), and the
precipitation procedure was repeated three times to obtain pure product (for the final precipitation 0.5
mL of MeOH was used with 5 mL of chloroform). The resulting white powder was dried under high
vacuum at 30𝑜 𝐶 for 24 hours to obtain the pure product with 94% yield (0.94 g). 1 𝐻 NMR (𝐶𝐷𝐶𝑙3 ,
500 MHz) �(174H, m), 5.18 (58H, m).(All the amounts and NMR chemical shifts are given for the 70(DL/L)-G3-BOC. For the 90,50 and 30 systems, procedure is the same but amounts of the materials are
varied as are the solvent amounts which are needed to dissolve each system. Analysed NMR spectra for
all the systems are given in the NMR spectra section).
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94
Figure 26: 1 𝐻 NMR of G0.5 PAMAM

95
Figure 27: 1 𝐻 NMR of G1 PAMAM

96
Figure 28: 1 𝐻 NMR of G1.5 PAMAM

97
Figure 29: 1 𝐻 NMR of G2 PAMAM

98
Figure 30: 1 𝐻 NMR of G2.5 PAMAM

99
Figure 31: 1 𝐻 NMR of G3 PAMAM

100
Figure 32: 1 𝐻 NMR of Boc-protected G3 PAMAM

101
Figure 33: 1 𝐻 NMR of Boc-protected 90-L-G3

102
Figure 34: 1 𝐻 NMR of Boc-protected 70-L-G3

103
Figure 35: 1 𝐻 NMR of Boc-protected 50-L-G3

104
Figure 36: 1 𝐻 NMR of Boc-protected 30-L-G3

Kinetics of Organocatalytic Polymerizations
Table 7: Organocatalyst kinetics study.
Catalyst

% equivalents

Monomer

Reaction time (h)

% monomer conversion

DMAP

40%

L-Lactide

6

0.0%

40%

L-Lactide

12

70%

95%

L-Lactide

12

91%

TBD

10%

L-Lactide

12

18%

DBU

20%

L-Lactide

4

100%

(90/70/50/30) – (DL/L) – G3 – 𝑁𝐻3+ 𝑇 𝐹 𝐴− (10) To a stirred solution of (6) (1g, 0.16
mmol) in chloroform (15 mL), trifluoroacetic acid (TFA) (1.5 mL, 10% v/v) was added and stirred for
30 minutes. The final reaction mixture was air dried to remove the TFA, dissolved in 5mL of chloroform
, and thenadded dropwise to 250 mL of diethyl ether. After stirring for 30 minutes, the reaction mixture
was allowed to settle down. The resulting white precipitate was filtered out, dissolved in chloroform
(5 mL), and the precipitation procedure was repeated three times to obtain pure product (for the final
precipitation 0.5 mL of MeOH was used with 5 mL of chloroform). The resulting white powder was dried
under high vacuum at 30 𝑜 𝐶 for 24 hours to obtain the pure product with 94% yield (0.94 g). 1 𝐻 NMR
(𝐶𝐷𝐶𝑙3 , 500 MHz) 𝛿 (174H, m), 5.18 (58H, m)
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LDBC Characterization
Table 8: Calculations for theoretical weights
MW

MW de-

MW

MW

MW de-

protected

protected

Lactide

protected

protected

Target

LDBC

dendron

dendron

Block

LDBC

LDBC

DP

90-L/DL-

2460

1667

15 003

17 463

16 670

208

2460

1667

3890

6350

5557

54

2460

1667

1667

4127

3334

23

2460

1667

714

3174

2381

10

G3
70-L/DLG3
50-L/DLG3
30-L/DLG3
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GPC

Figure 37: GPC chromatograms of Boc-protected PAMAM-PLA LDBCs in DMF
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MALDI

Figure 38: MALDI of Boc-protected G3 PAMAM
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Figure 39: MALDI of G3 PAMAM after reprotection with acetic anhydride
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Nanoparticle characterization
DLS

Figure 40: DLS spectra for 70-L-G3-BOC direct dissolution; left: Size distribution by intensity, right: Size
distribution by volume

Figure 41: DLS spectra for 50-L-G3-BOC direct dissolution; left: Size distribution by intensity, right: Size
distribution by volume
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Figure 42: DLS spectra for 30-L-G3-BOC direct dissolution; left: Size distribution by intensity, right: Size
distribution by volume

Figure 43: DLS spectra for 70-DL-G3-BOC direct dissolution; left: Size distribution by intensity, right: Size
distribution by volume
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Figure 44: DLS spectra for 50-DL-G3-BOC direct dissolution; left: Size distribution by intensity, right: Size
distribution by volume

Figure 45: DLS spectra for 30-DL-G3-BOC direct dissolution; left: Size distribution by intensity, right: Size
distribution by volume
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TEM

Figure 46: Additional TEM of 30-L-G3

Figure 47: Additional TEM of 50-L-G3
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Figure 48: Additional TEM of 70-L-G3

Figure 49: Additional TEM of 30-DL-G3
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Figure 50: Additional TEM of 50-DL-G3

Figure 51: Additional TEM of 70-DL-G3
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CAC

Figure 52: Excitation ratio vs. concentration for L series

Figure 53: Excitation ratio vs. concentration for DL series
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APPENDIX B: SUPPLEMENTARY INFORMATION FOR
CHAPTER 3

Synthesis
mCTA synthesis and Characterization

Figure 54: bMPA Monomer synthesis

bMPA bMPA monomer was made as previously described. Briefly, 2,2-bis(hydroxymethyl)propionic
acid (100 g, 0.746 mol) was stirred in acetone (500 mL) and 2,2-dimethoxypropane (138 mL, 1.12 mol)
at room temperature until the solution turned transparent. Then, para-toluenyl sulfonic acid (6.42g,
37.3 mmol) was added, and the reaction was stirred for 4h. The crude product was percolated through
a column of Amberlyst-A21 resin. The eluent was concentrated in vacuo, and then dissolved in 300mL
DCM and stirred 6h. Any solid that crashed out was removed by vacuum filtration over Celite. The
filtrate was added dropwise to 1L of hexanes and stirred 30 min, then allowed to sit for 30 min. The
resulting white solid was vacuum filtered, yielding bMPA as a white, amorphous solid. Yield = 79.6g
(61.2%) 1H NMR (300 MHz, Chloroform-d) � 4.20 (d, J = 12.0 Hz, 2H), 3.68 (d, J = 11.8 Hz, 2H), 1.48
– 1.39 (m, 6H), 1.22 (s, 3H).
az-mpa-4 was grown by the general esterification procedure. After activating bMPA (14.9 g,
85.6 mmol) suspended in 43mL EtOAc with CDI (13.9g, 85.6 mmol), CsF (2.08g, 13.7 mmol) and 2(azidomethyl)-2-methylpropane-1,3-diol (4.14 g, 28.5 mmol) were added and stirred overnight, yielding
az-mpa-4 as a light yellow oil. Yield = 11.9g (92%) 1H NMR (400 MHz, Chloroform-d) � 4.21 (d, J
= 11.6 Hz, 4H), 4.11 (s, 4H), 3.68 (d, J = 11.6 Hz, 5H), 3.40 (s, 2H), 1.42 (d, J = 25.7 Hz, 13H), 1.17
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Figure 55: Pathway to G3 dendron

(s, 6H), 1.08 (s, 3H). Solvent impurites: EtOAc, Water.

13

𝐶 NMR (75 MHz, 𝐶𝐷𝐶𝑙3 ) � 173.77, 98.16,

66.13, 65.94, 55.11, 42.23, 40.02, 25.82, 21.45, 18.45, 17.69.
az-mpa-4OH az-mpa-4 was deprotected using the general deprotection procedure outlined
above. After overnight stirring, the crude product was dried in-vacuo and suspended in petroleum ether.
Enough activated charcoal was added to make the solution opaque, and this was stirred overnight. This
was filtered over Celite and concentrated in-vacuo, quantitatively yielding az-mpa-4OH as a clear oil.
1H NMR (400 MHz, 𝑀𝑒𝑡ℎ𝑎𝑛𝑜𝑙 − 𝑑4 ) � 4.06 (s, 4H), 3.73 (d, J = 10.7 Hz, 4H), 3.64 (d, J = 10.8 Hz,
4H), 3.45 (s, 2H), 1.20 (s, 6H), 1.07 (s, 3H).

13

𝐶 NMR (75 MHz, MeOD) � 174.74, 65.56, 64.50, 54.98,

50.50, 47.32, 47.04, 46.75, 39.36, 16.60, 15.92.
az-mpa-8 was grown according to the general esterification procedure. After activating bMPA
(15.7g, 90mmol) suspended in 45 EtOAc with CDI (16.1g, 99mmol), CsF (2.10g, 13.8mmol) and 5.66g
az-mpa-4OH were added and stirred 3h, yielding az-mpa-8 as a honey-colored oil. Yield = 12.6g (84%).
1

𝐻 NMR (300 MHz, Chloroform-d) � 4.45 (s, 8H), 4.15 (d, J = 11.8 Hz, 8H), 4.02 (s, 4H), 3.63 (d, J =

12.0 Hz, 8H), 3.35 (s, 2H), 1.39 (d, J = 18.6 Hz, 2rH), 1.31 (s, 6H), 1.14 (s, 12H), 1.03 (s, 3H). Solvent
impurities: acetone, EtOAc, water

Figure 56: DDPET Synthesis

DDMAT Potassium phosphate (4.2 g, 1.1 eq, 20 mmol) was suspended in acetone (60 mL) in a
2-necked, 100mL round-bottomed flask. 𝑁2 was bubbled through the solution for 30 minutes. Dodecane-
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1-thiol (4.0 g, 4.73 mL, 1.1 eq, 20 mmol) was added over 25 minutes via syringe pump. Carbon disulfide
(4.1 g, 3.24 mL, 3 eq, 54 mmol) was then added and stirred 10 minutes. 2-Bromo-2-methylpropanoic
acid (3.0 g, 1 eq, 18 mmol) was added under 𝑁2 . This was stirred until completion by NMR. After
48h, acetone was removed in-vacuo. The resulting yellow solid was dissolved in 200mL 1M HCl. The
water layer was extracted with 2x200mL DCM. The combined organic fractions were washed with 200mL
water and 200mL Brine. The organic fractions were dried with MgSO4 and concentrated in-vacuo. The
resulting orange solid was recrystallized from 30mL hexanes, yielding DDMAT as a yellow crystal. Yield
= 3.3g (50%). 1 𝐻 NMR (300 MHz, Chloroform-d) � 3.28 (t, J = 7.4 Hz, 2H), 1.73 (s, 6H), 1.66 (q, J =
7.6 Hz, 2H), 1.26 (s, 16H), 0.92 – 0.84 (m, 3H).
DDPET DDMAT (3.0 g, 1 eq, 8.2 mmol), EDC (2.4 g 1.5 eq, 12 mmol) and DMAP (1.5 g, 1.5
eq, 12 mmol) were combined and degassed in an oven-dried flask. 30 mL anhydrous DCM was added,
and the solution was cooled to 0𝑜 𝐶. Propargyl alcohol (1.5 g, 1.6 mL, 3.3 eq, 27 mmol) was added
dropwise. The reaction was allowed to warm to room temperature and stirred for 72h. The crude was
diluted with 120 mL DCM and washed with 2x30 mL 1M 𝑁𝑎𝐻𝑆𝑂4 , 2x30 mL water, and 1x30 mL
brine. This yielded DDPET as an orange oil. Yield = 3.18 g (96%) 1 𝐻 NMR (300 MHz, Chloroform-d)
� 4.70 (d, J = 2.5 Hz, 2H), 3.27 (t, J = 7.4 Hz, 2H), 2.46 (t, J = 2.5 Hz, 1H), 1.71 (s, 6H), 1.66 (t, J =
7.5 Hz, 2H), 1.26 (s, 16H), 0.93 – 0.83 (m, 3H). Solvent impurites: water, acetone

Figure 57: N-Boc Alanine Synthesis
N-Boc Alanine 3-Aminopropanoic acid (5.0 g, 1 eq, 56 mmol) was dissolved in THF (40
mL) and 1M NaOH (50 mL) and cooled to 0𝑜 𝐶. Di-tert-butyl dicarbonate (12 g, 1.02 eq, 57 mmol) was
added and stirred overnight at rt. THF was removed _in _vacuo and the crude was washed with 75mL
𝐸𝑡2 𝑂, which was discarded. The crude was acidified to pH 2 with 6M HCl. This was extracted with
5x37 mL 𝐸𝑡2 𝑂. The combined ether fractions were washed with 37 mL brine. The combined ether
fractions were dried with 𝑀𝑔𝑆𝑂4 and concentrated in-vacuo. After additional drying in a vacuum oven
at room temperature, N-Boc Ala was yielded as an amorphous white solid. Yield = 5.8g (55%) 1 𝐻
NMR (300 MHz, Chloroform-d) � 5.06 (s, 1H), 3.40 (d, J = 7.6 Hz, 2H), 2.58 (s, 2H), 1.45 (s, 9H).
cta-mpa-8 az-mpa-8 (1.13 g, 1.13 mmol) and DDPET (545mg, 1.35mmol) were dissolved
in THF (12mL) and

water (4.1 mL) and degassed with 𝑁2 for 30 minutes. Copper(II) sulfate

pentahydrate (155 mg, 620 𝜇mol) was then added, followed by sodium citrate (290 mg, 1.47 mmol)
This was stirred overnight at room temperature. The crude product was dissolved in 15mL EtOAc
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Figure 58: mCTA synthesis

followed by washing with 2x5mL 1% EDTA. This was then purified by flash chromatography (gradient
from 80:20 hexane:EtOAc to 0:100 hexane:EtOAc), yielding cta-mpa-8 as an orange oil. Yield = 806mg
(51%). 1H NMR (400 MHz, Chloroform-d) � 7.67 (s, 1H), 5.23 (s, 2H), 4.45 – 4.30 (m, 10H), 4.15 (t, J
= 8.0 Hz, 8H), 4.02 (s, 4H), 3.63 (d, J = 11.8 Hz, 8H), 3.24 (t, J = 7.4 Hz, 2H), 1.73 – 1.62 (m, 6H),
1.38 (d, J = 28.9 Hz, 30H), 1.30 – 1.20 (m, 24H), 1.18 – 1.08 (m, 15H), 1.00 (s, 3H), 0.88 (t, J = 6.5 Hz,
3H). Solvent impurities: water, EtOAc.
cta-mpa-8OH 806mg cta-mpa-8 was deprotected using the general deprotection procedure.
After 24h stirring, the crude vacuum filtered and dried in-vacuo, yielding cta-mpa-8OH (4.7) as a dark
orange oil. Yield = 666 mg (94%).

1

𝐻 NMR (300 MHz, 𝑀𝑒𝑡ℎ𝑎𝑛𝑜𝑙 − 𝑑4 ) � 8.05 (s, 1H), 5.24 (s, 2H),

4.55 (s, 2H), 4.35 (qd, J = 11.0, 3.0 Hz, 8H), 4.11 (s, 4H), 3.77 – 3.55 (m, 16H), 1.68 (s, 6H), 1.63 (d,
J = 7.4 Hz, 2H), 1.36 (s, 6H), 1.32 (s, 16H), 1.17 (s, 12H), 1.06 (s, 3H), 0.96 – 0.86 (m, 3H). Solvent
impurities: acetone, MeOH
cta-mpa-8ala-Boc 666 mg cta-mpa-8OH was grown using a slightly modified variant of the
general esterification procedure. After activating N-Boc alanine (1.22 g, 6.24 mmol) suspended in 7 mL
EtOAc with CDI (1.15 g, 7.06 mmol), CsF (158 mg, 1.04 mmmol) and cta-mpa-8OH (666 mg, 535 𝜇mol)
were added and stirred overnight, yielding cta-mpa-8ala-Boc as a dark orange resin. Yield = 1.17 g
(84%).

1

𝐻 NMR (300 MHz, Chloroform-d) � 7.72 (s, 1H), 5.23 (s, 6H), 4.43 (s, 2H), 4.36 – 4.14 (m,
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23H), 4.05 (s, 4H), 3.37 (d, J = 6.3 Hz, 14H), 3.24 (t, J = 7.4 Hz, 2H), 2.54 (t, J = 6.1 Hz, 16H), 1.43 (s,
72H), 1.31 (s, 6H), 1.29 – 1.21 (m, 30H), 1.03 (s, 3H), 0.91 – 0.84 (m, 3H). Solvent impurities: EtOAc,
water
mCTA cta-mpa-8ala-Boc (1.17 g) was dissolved in 6 mL 𝐶𝐻𝐶𝑙3 and 4 mL TFA. This was
stirred at rt for 1.5 h, then concentrated in-vacuo. The resulting crude was precipitated in 50 mL diethyl
ether cooled to 0 𝑜 𝐶, and the precipitate was dried in a vacuum oven at room temperature for 48h.
Yield = 610 mg (88%).

1

𝐻 NMR (300 MHz, 𝐷𝑀𝑆𝑂 − 𝑑6 ) � 8.12 (s, 1H), 7.96 (s, 27H), 5.17 (s, 2H),

4.51 (s, 2H), 4.22 (d, J = 19.4 Hz, 24H), 3.98 (s, 4H), 3.11 – 2.96 (m, 18H), 2.67 (t, J = 7.1 Hz, 16H),
1.60 (s, 6H), 1.36 – 1.14 (m, 32H), 0.87 (dd, J = 14.6, 8.6 Hz, 6H). Solvent impurities: 1,4-dioxane

Figure 59: 1 𝐻 NMR of bMPA
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Figure 60: 1 𝐻 NMR of az-mpa-4

Figure 61:

13

𝐶 NMR of az-mpa-4
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Figure 62: 1 𝐻 NMR of az-mpa-4OH

Figure 63:

13

𝐶 NMR of az-mpa-4OH
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Figure 64: 1 𝐻 NMR of az-mpa-8

Figure 65: 1 𝐻 NMR of DDMAT
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Figure 66: 1 𝐻 NMR of DDPET

Figure 67: 1 𝐻 NMR of N-Boc-alanine
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Figure 68: 1 𝐻 NMR of cta-mpa-8

Figure 69: 1 𝐻 NMR of cta-mpa-8OH
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Figure 70: 1 𝐻 NMR of cta-mpa-8ala-Boc

Figure 71: 1 𝐻 NMR of mCTA
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Figure 72: Superposition of 1 𝐻 NMR for pBzMA PISA over time

Figure 73: Superposition of 1 𝐻 NMR for pTsP PISA over time . Peaks at 4.83 and 5.18 ppm correspond to
TFEMA and PyMMA monomer, respectively.
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Figure 74: 1 𝐻 NMR of final timepoint for 67:33 pBzMA PISA

Figure 75: 1 𝐻 NMR of final timepoint for 83-17 pBzMA PISA
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Figure 76: 1 𝐻 NMR of final timepoint for 67:33 pTFEMA PISA

Figure 77: 1 𝐻 NMR of final timepoint for 67:33 pTsP PISA
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Nanoparticle characterization
CAC
For critical aggregation concentration (CAC) measurements of pBzMA and pTFEMA, pyrene
(1.7 mg, 8.41 �mol) was dissolved in 3.34 mL of acetone and 40 �L of the solution was added to 39.96 mL of
deionized water. A series of 12 concentrations of the nanoparticle suspension ranging from 10−8 𝑚𝑔𝐿−1
to 1000 𝑚𝑔𝐿−1 was prepared by serial dilution, resulting in a volume of 1.8 mL sample per concentration.
A 1.8 portion mL of the pyrene solution was added to each vial, and these solutions were equilibrated for
48 h in the absence of direct light. The fluorescence spectra were obtained on a Varian Cary fluorescence
spectrometer from Agilent Technologies. An emission wavelength of 390 nm was used for pyrene and
the excitation spectra were recorded from 300 to 360 nm. The ratio of emission intensities at 338 and
333 nm was graphed as a function of the log of the concentration. The CAC was determined as the
concentration at the intercept of the lines for the two linear regions of the obtained graphs.

Figure 78: CAC measurements of pBzMA and pTsP at full conversion
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TEM

Figure 79: TEM of mCTA
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Copyright Permissions

Figure 80: Copyright Permission for Fig. 15
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